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Materials Science

Electrospun Fibers with Smart Delivery of Therapeutic Agents
Chairperson: Andrij Holian
Electrospinning is the most widely studied technique of producing fibers. Delivery of
nanoparticles and therapeutic agents from electrospun fibers have potential uses in various fields
including drug delivery, filtration, and cosmetics. However, controlling the delivery rate remains
the main challenge. In the current study, core-shell structure fibers were developed with zinc
oxide nanoparticles applied in the shell composition to improve the pore structure (release
pathway) and mechanical stability. Fine-tuned delivery rates were achieved via loading different
sizes of silver nanoparticles (Ag NP) inside the fiber core. In vitro drug release assays showed
fast, slow, and intermediate delivery rates of 20 nm Ag NP, 110 nm Ag NP, and a mix of the two
Ag NP, respectively. In the next step, temperature-controlled delivery rates were achieved via
loading thermoresponsive microgel particles of poly(n-isopropylacrylamide) in addition to Ag
NP inside the fiber core. In vitro drug release assays showed a fast release of Ag NP above the
transition temperature and a slow release below the transition temperature. Ball-milling of the
hydrogel was developed as a versatile, simple, and high yield technique of producing microgel
particles (microgels). In vitro antibacterial tests confirmed the efficacy of the fiber meshes for
anti-infection applications. Subcutaneous implantation of fiber meshes in a mouse model
confirmed the in vivo drug release performance of the fibers. Fiber meshes were had appropriate
biocompatibility and mechanical stability. The thorough characterization, in vitro and in vivo
analyses of the fiber meshes confirmed their potential for prolonged drug delivery applications.
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Electrospinning: significance and technique
Electrospun fibers have attracted significant attention for their outstanding characteristics
such as high surface area to volume ratio, adjustable surface morphology, and high
interconnected mesh porosity (1). Electrospinning is recognized as the most popular technique
for fabrication of nanofibers due to its simplicity, cost efficiency, versatility, and the possibility
of large-scale production (1–4). Potential applications of electrospun fibers range from
biomedical, filtration, agriculture and food industry, energy, sensors, and textiles. An overview
of some of these applications is presented in Table 1.1.
Table 1.1 Potential applications of electrospun fibers.
Tissue scaffolds (5–8), wound dressings (9–13), cancer treatment (14–
Biomedical

16), surgical Meshes (17,18), vascular grafts (19–21), heart patches (22–
24), and drug delivery (25,26)

Filtration
Agriculture and
food industry
Energy
Sensors
Technical textile

Air and water filtration (27,28) and affinity membranes (29,30)
Biosensors (31), encapsulation (32), and food packaging (33,34)
Solar (35,36) and fuel cells (37–39), supercapacitor (40,41), and
actuators (42,43)
Gas, chemical, optical (44,45), and piezoelectric sensors (46,47)
Protective clothing (48,49), performance textile (46), and breathable
textile (50)

Electrospun fibers are produced from a polymeric solution by application of high electric
voltage between a spinneret and a collector. When an applied electric field overcomes the
cohesive forces (mostly dominated by surface tension) of the polymeric solution at the capillary
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tip, an electrically charged jet of polymer solution is drawn toward the collector. While the jet
travels in the air, the solvent evaporates and the jet solidifies into fibers. Electrospinning
provides non-woven fiber meshes with diameters from tens of microns down to tens of
nanometers (51,52).
Electrospun fiber meshes in biomedical applications
Reviewing published studies on various applications of electrospun fibers reveals that
electrospun fibers are well-known for biomedical applications, which can be due to their unique
structure (53). In wound dressing applications, a flexible and porous structure of fiber meshes
allows for liquid and gas permeability, and thus facilitates hemostasis, cell respiration, regulated
moisture level, and a suitable bacterial barrier (12,13,54). In tissue engineering applications, the
structure of electrospun fiber meshes similar to extracellular matrix (ECM) increases the cell
interaction and nutrient diffusion, and thus facilitates tissue growth into the fiber mesh (55,56).
Moreover, electrospun fiber meshes can be deposited as a thin layer on the surface of prostheses
and implants to increase the surface area, improve the biocompatibility, and reduce friction, thus
reducing the prosthetics failure rate by improving the implant-tissue interaction (57–59). Table
1.2 presents an overview for some biomedical applications of fiber meshes and their
advantageous properties for each application.
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Table 1.2 Biomedical applications of electrospun fibers and their advantageous properties for
these applications. Therapeutic agents/drugs loaded into the electrospun fibers for development
of drug delivery systems.
Application

Advantages

Loaded drugs (purpose)

Regulate the moisture level
Allows for oxygen diffusion
Wound dressing

Bacterial barrier

Growth factors (60–62)
Antibiotics (63–65)
Viruses (66–68)
Vitamins (69–71)

Facilitates homeostasis

Hemostatic agents (72–74)
Analgesics (75–77)

Cancer treatment

Prosthetic coating
Tissue engineering
(vascular grafts,
bone scaffolds, skin
grafts, heart patches,

Isolating the tumor

Anticancer drugs (78–80)

Localization of drug delivery
Providing an interactive surface

Antibacterial agents (81–83)

Reducing the infection risk

Bone regenerative (59,84,85)

Resembling ECM structure
Allowing for diffusion of
nutrients and wastes

Growth factors and stem cells (86–89)
Proteins (90–93)
Antibiotics (94)
Polypeptides (95,96)

surgical meshes, etc)

Anticoagulant (97–99)
Bone regenerative nano/microparticles

Bone scaffolds

Providing suitable surface for

(β‐tricalcium phosphate (100,101),

bone regeneration

hydroxyapatite (102–104), bioactive
glass (94,105,106))
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A distinguishing advantage of electrospun fiber meshes is the possibility of loading
therapeutic agents for development of drug delivery systems (107). Drug delivery can be
accompanied with any biomedical application of fiber mesh use in order to improve the outcome
(107). Furthermore, loading drugs into fiber meshes can provide local drug deliveries for
administration of high and sustained drug concentrations without the need for large systemic
doses, thus reducing the off-target tissue toxicities (108). Consequently, a great number of
studies have been performed in attempts to develop fiber meshes with drug delivery properties.
Therapeutic agents ranging from antibiotics, growth factors, viruses, vitamins, analgesics, etc.
have been incorporated into electrospun fibers. An overview of these drug delivery systems is
presented in Table 1.2.
Development of drug delivery systems made of fiber meshes: methods and challenges
Therapeutic agents/drugs can be loaded into electrospun fibers before or after the
electrospinning (pre- or post-electrospinning) (109). The major methods of pre-electrospinning
drug loading are illustrated in Figure 1.1.
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Blend

Emulsion

Coaxial

Figure 1.1 Schematic illustration of the electrospinning syringe set up and a fiber product for
three major methods of pre-electrospinning drug loading: (A) blend electrospinning, (B)
emulsion electrospinning, and (C) coaxial electrospinning.
The basic method used for loading drugs into electrospun fiber meshes is blend
electrospinning in which a solution of polymer and drug is used during the electrospinning
process (Figure 1.1A). The main advantage of this method is a simple electrospinning set up and
less complications for adjusting the electrospinning parameters. A proper distribution of drugs in
the solution and later in the electrospun fibers is a crucial factor to have a sustained delivery.
However, most drug molecules migrate to the fiber surface with the evaporation of solvents
during the electrospinning process. Accumulation of drug molecules at the surface of fibers
causes sudden release of drugs, defined as the burst release effect. Since electrospun fibers have
the potential for burst release due to their high surface area to volume ratio, surface accumulation
of drugs exacerbates the burst release (110). Another challenge in this method is that being
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blended in the electrospinning solution, drugs can be harmed by the organic solvents and harsh
conditions of electrospinning (such as high voltage and rapid changes in the vapor pressure).
Therefore, an important limitation of this method is difficulty for loading fragile drugs or
bioactive agents into the fibers.
A more advanced method for incorporation of drugs is emulsion electrospinning in which
two liquids, stabilized by an emulsifier, are used for the electrospinning process (Figure 1.1B). In
this method fragile drugs are protected from solvents used in the polymer solution. Emulsion
properties and electrospinning parameters can be manipulated in this method to form fibers with
a core-shell structure. The advantage of the core-shell structure is that the fiber shell provides a
barrier to reduce the burst release. In practice, adjusting the electrospinning parameters is
challenging in this method. In many studies, fibers with a dispersed phase of droplets are
reported instead of the core-shell structure (Figure 1.1B) (111). Moreover, selecting a stable
polymer-drug emulsion system brings limitations to this method. An unstable emulsion results in
agglomeration and localization of drugs on the surface of fibers, which results in the burst release
problem (112).
The core-shell structure can also be produced via coaxial electrospinning in which two
immiscible solutions (core and shell) are electrospun simultaneously through a coaxial spinneret
(Figure 1.1C). The main advantage of this method is protecting bioactive or fragile therapeutic
agents from organic solvents and harsh electrospinning conditions. In this method, drug
molecules can be loaded inside the core or (less-fragile drugs) can be blended with the shell
solution. Drugs loaded in the shell release via desorption/leaching into the surrounding liquid
media i.e. erosion/degradation of the shell (111,113). To release drugs loaded in the core, pores
are formed in the shell using porogens. A porogen is a polymer added into the shell solution
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before electrospinning. The porogen is selectively dissolved or melted away from the fibers after
electrospinning resulting in pores formed in the shell structure. Although application of porogen
in the shell seems suitable for drug release, in practice, high percentages of porogens are needed
to form pores that are connected to the core (“interconnected pores” or “open pores”).
Application of high percentages of porogens cause rupture/swelling and failure of the shell
structure when dissolved, resulting in an uncontrolled and burst release of the drug (114,115).
Therefore, controlling the pore structure while maintaining the fiber integrity is a crucial
challenge of drug delivery in core-shell structured fibers.
Electrospun fiber meshes and the potential for smart drug delivery
Smart drug delivery systems are drug carriers that can be stimulated with the changes of
temperature, pH, light, electromagnetic fields, and mechanical forces to release drugs (116).
Compared to conventional drug delivery systems, stimuli-responsive delivery further improves
the drug targeting efficacy, thus minimizing the off-target tissue toxicities (117). For instance, a
thermoresponsive drug delivery system can release an antibacterial drug upon the temperature
increase of the infected tissue. Localized and responsive delivery of such a system improves
treatment efficacy, reduces cost and discomfort, and prevents the overuse of antibacterial drugs
which can cause antibacterial resistance (118). Consequently, fabrication of stimuli responsive
electrospun fibers has attracted attention due to their importance in drug delivery applications.
Figure 1.2 reviews the main electrospun fiber structures developed from poly(nisopropylacrylamide) (PNIPAM), which is a thermoresponsive polymer. PNIPAM is the most
studied thermoresponsive polymer for drug delivery applications because it has a transition
temperature close to human body temperature.
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Figure 1.2 Schematic illustration of fiber structures developed from electrospinning of PNIPAM.
The basic method used to produce thermoresponsive fiber meshes is electrospinning
monolithic fibers in which a solution of PNIPAM is used for electrospinning (Figure 1.2) (119).
This method requires a simple electrospinning set up with fewer complications while adjusting
the electrospinning parameters. However, fibers made in this method lack suitable mechanical
properties and stability in aqueous solutions (120). Suitable mechanical properties of electrospun
fibers is an important factor to prevent the burst release and obtaining a long term and controlled
drug release (121,122). Furthermore, mechanical properties are especially important for
thermoresponsive (or stimuli-responsive) fibers because release of these polymers into the tissue
can cause toxicity (123).
Post-electrospinning crosslinking of the PNIPAM fibers is another method, which was
mainly developed to improve the mechanical properties (Figure 1.2B). Post-crosslinking is
performed by heating fibers or exposing fibers to ultraviolet light (124,125). This method results
in better mechanical properties and a controlled drug release. However, it is not possible to load
fragile bioactive agents in this method, because they are susceptible to denaturation under the
harsh crosslinking conditions and organic solvents (126).
10

Electrospinning a PNIPAM blended or copolymerized with another polymer also
improves the mechanical properties of the fibers (Figure 1.2C) (124). In this method, a drug
could be also blended into the electrospinning solution (Figure 1.1A). Therefore, a simple
electrospinning procedure is an advantage of this method. However, drug release rate is poorly
controlled (127). Harsh electrospinning conditions and solvents in this method prevent loading
fragile or bioactive agents. A more advanced group of fibers are core-shell structured with
PNIPAM in the shell and a strong polymer, such as polycaprolactone, in the core (Figure 1.2D)
(128,129). These fibers have better mechanical properties due to the strong core. However,
PNIPAM in the shell has a high degree of hydrophilicity and can dissolve/detach from the fibers
in an aqueous media (which is the common drug delivery media). Instability of PNIPAM results
in burst release of drugs and also induces toxicity.
In one study (130), core-shell fibers with PNIPAM in the core and polyurethane in the
shell were developed. The core-shell fibers were compared to fibers produced from a blend of
PNIPAM and polyurethane (method 2C). It was shown that the burst release, seen in the blend
fibers, were reduced in the core-shell fibers. However, no drug release pathway was formed in
core-shell fibers. Therefore, the drug release profile reached a plateau after 10 h of immersion
with 58% of drug trapped inside the fibers.
Purpose of the study
To our knowledge, electrospun fibers developed prior to this study could not address all
the discussed problems simultaneously. For example, improving the mechanical properties via
post-crosslinking prevented the possibility of loading bioactive agents. Therefore, the purpose of
this study was to develop electrospun fibers with prolonged and controlled drug release, suitable
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mechanical properties, and minimum toxicity, whilst having the possibility of loading fragile
drugs or bioactive agents. These goals were addressed in three sections as follows.
First (Chapter 2), the core-shell fiber structure was chosen for the drug delivery method
because it is possible to load fragile drugs or bioactive agents inside the core. Zinc oxide
nanoparticles (ZnO NP) were applied in the shell composition to form open pores while
improving the mechanical properties because these are necessary factors to avoid burst release
and control the release rate. Silver nanoparticles (Ag NP) were loaded in the fiber core as a
model antibacterial drug, but could be replaced by other therapeutic agents or nanoparticles for
different applications. Different sizes of Ag NP were applied to fine-tune the release rate via
controlling the diffusion rate of nanoparticles through the pores.
Second (Chapter 3), PNIPAM microgel particles were loaded in the core in addition to
Ag NP to obtain a temperature-responsive release of Ag NP. Loading PNIPAM microgel
particles protected the microgel from harsh conditions of electrospinning which can induce the
hydrophilic to hydrophobic transition and thus unwanted release of drugs. Moreover, loading
PNIPAM microgel particles in the core prevented their contact with solvents used in the shell
solution, thus preventing any unwanted phase transition or reaction of microgel. Another
advantage was preventing direct contact of the PNIPAM microgel particles with the tissue and
thus reducing any possible toxicity. The PNIPAM microgel particles were produced via a novel
use of ball milling. This method is simple, versatile, and nontoxic hence allows for particle
production from various kinds of stimuli-responsive microgels.
Third (Chapter 4), in vitro and in vivo assessments of the developed fiber meshes were
performed to evaluate their efficacy. Antibacterial and cytotoxicity measurements of the fiber
meshes were performed in vitro. Since the body fluid dynamic differs from the in vitro drug
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release studies, performing animal model studies were essential to confirm the efficacy of fiber
meshes. Histological studies of the fiber meshes were performed to evaluate tissue responses to
the fiber meshes.
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Abstract
Electrospun fiber meshes with controlled drug delivery properties have great potential for
applications such as wound dressings, tissue engineering, and cancer treatment. However,
controlling the drug release, especially from core-shell fibers, remains the main challenge. In this
study, core-shell fibers were developed with silver nanoparticles (Ag NP, as an antibacterial
agent) loaded in the core. To control the release rate, pore structure in the shell (diffusion
pathway for Ag NP) was improved compared to previous studies by a novel use of ZnO NP
combined with polyethylene glycol (as the porogen). Moreover, the diffusion/release rate of Ag
NP from electrospun fibers was fine-tuned with variation in particle size. Fibers were loaded
with three size compositions of 20 nm, 110 nm, or a mix of the two Ag NP inside the fiber core.
Release studies showed fast, slow, and intermediate delivery rates obtained with the defined Ag
NP. Fine-tuned release of Ag NP confirmed the formation of open pores within a stable shell
structure because controlling the release rate was only possible through this well-defined release
pathway. Furthermore, tensile strength analysis revealed excellent mechanical stability of the
fibers after pore formation.
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Ag: fast (1), intermediate (2), and slow (3) release of 20, 20+110, 110 nm Ag NP from the fiber
core through pores. Zn: sustained release of ZnO NP from fiber shell.
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Introduction
Among various methods of fabricating fiber meshes, electrospinning is the most popular
process due to its simplicity, cost efficiency, versatility, and the possibility of large-scale
production (1,2). Potential applications of electrospun fibers range from biomedical, filtration,
energy, sensors, and food industry (3–5). Electrospun fibers are being primarily developed for
biomedical applications due to their unique structure i.e. high surface area to volume ratio, high
interconnected mesh porosity, and similar structure to the extracellular matrix (6,7). The
distinguishing advantage of electrospinning for biomedical applications is the possibility of
incorporating drugs into the fibers. Furthermore, development of coaxial electrospinning
facilitates the ability to load various therapeutic agents, including fragile drugs and biomolecules,
inside the fiber core (8).
In order to release the encapsulated agents from the fiber core, a porogen, which is
usually a water-soluble polymer such as polyethylene glycol (PEG), needs to be added into the
shell (9–13). The porogen dissolves (by selective dissolution) to form open pores required for the
release of agents from the core. However, in practice, high percentages of porogen in the shell
composition are needed to obtain open pores. Unfortunately, using high percentages of porogen
results in fiber rupture or swelling, and failure of the shell structure. This failure in turn results in
an uncontrolled and sudden release of agents within one or few hours (14–21). To control the
release rate, therefore, it is crucial to form pores without disrupting the shell structure.
In this project, zinc oxide nanoparticles (ZnO NP) were included into the fiber shell to
overcome the challenge of creating open pores without losing the fiber stability. ZnO NP have
been used in electrospun fibers to improve the mechanical properties, but not in combination
with porogen to form pores (22–24). Silver nanoparticles (Ag NP) were used as a model drug in
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this study, but could be replaced by other therapeutic agents for different applications. Ag NP
have been incorporated into electrospun fibers for their antiseptic, antibacterial, antiinflammatory properties (25). However, the release rate of Ag NP from electrospun fibers has
not been well controlled (26–34). In this study, commercially available Ag NP were used inside
the core to control the release rate through the pores. Two different sizes of Ag NP were used in
the core with the goal of fine-tuning the release rate. It was hypothesized that this unique
structure would have two distinct delivery rates: (i) fast diffusion of smaller Ag NP through the
formed pores, (ii) slow diffusion of larger Ag NP through the pores.
Materials and methods
Polycaprolactone (PCL, MW = 45,000 g/mol), Poly(ethylene glycol) (PEG, BioUltra, Mw
= 3,350 g/mol), Chloroform (biotechnology grade, ≥99.8%, 0.5-1.0% ethanol as stabilizer), N,NDimethylformamide

(DMF,

ReagentPlus,

≥99%),

and

fluorescein

isothiocyanate

diethylaminoethyl dextran (FITC–DEAE–Dextran, Mw = 70,000 g/mol) were purchased from
Sigma-Aldrich, USA. Citrate coated silver nanoparticles (Ag NP, 20 nm and 110 nm diameter, 1
mg/mL) stabilized in 2 mM sodium citrate aqueous solution were obtained from NanoComposix
(BiopureTM, San Diego, CA, USA). Zinc oxide nanoparticles were obtained from Meliorum
Technologies, Inc. (ZnO NP, 20 nm diameter, Rochester, NY, USA). Characterization
information of ZnO NP and Ag NP are available in our previous studies (35,36). Ultrapure MiliQ water, obtained from a Milli-Q water purifier (QGARD00D2, Millipore, USA), was used
throughout this study.
Electrospinning of core-shell fibers
Data in Table 2.1 shows the sample designation and composition for each of the
fabricated fiber meshes. Samples were designated according to the size of Ag NP used for their
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fabrication. For the core feed fluids, different concentrations of Ag NP suspensions were
prepared by diluting the stock suspension of the Ag NP concentrates in water. Ag NP were used
as an antibacterial agent to be released from the core. For the shell feed fluids, a mixture of
chloroform/DMF with a ratio of 17:10 was used as the solvent for different compositions of
PCL, PEG and ZnO NP shown in Table 2.1.
An in-house built coaxial electrospinning instrument was used for fabrication of coreshell fibers. The spinneret-collector was arranged horizontally with a distance of 20 cm. A
prebuilt blunt coaxial spinneret (100-10-COAXIAL-2016, ramé-hart instrument Co.) with a 20gauge inner needle and a 16-gauge outer needle was used. Core and shell fluids were pumped
into the inner and outer needles with the feeding rates of 0.4 mL/h and 1 mL/h, respectively.
Fiber meshes were collected on a rotating drum (226 rpm, 5.08 cm diameter) that was covered
with aluminum foil. The spinneret was connected to a DC power supply and the collector
grounded. Applied voltages for different fiber compositions are shown in Table 2.1.
Electrospinning was performed in an electrically-insulated plastic case and placed inside a
laboratory safety hood (room temperature of 20C and ambient humidity of 10%). Fiber meshes
were fabricated by 1h of electrospinning. Then, fiber meshes were left inside the hood to dry
overnight.
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Table 2.1 Fabricated electrospun fiber meshes and their corresponding sample names
Shell Composition
Sample

Core Composition (Particle

Voltage

Diameter)

PCL

PEG

ZnO NP

(Wt%)

(Wt%)

(Wt%)

(KV)

F-Ag20

0.02 Wt% Ag NP (20 nm)

14

7

1.6

20

F-Ag110

0.02 Wt% Ag NP (110 nm)

14

7

1.6

21

14

7

1.6

21

F-AgMix

0.01 Wt% Ag NP (20 nm) +
0.01 Wt% Ag NP (110 nm)

F-ZnO

water

14

7

1.6

17

F-PEG

water

14

7

-

16

Nanoparticles release rate and weight loss measurements
Samples with a size of 15  3 cm2 were cut from the center of electrospun fiber meshes
(F-Ag20, F-Ag110 and F-AgMix). Fiber meshes were placed in water for a few seconds and then
quickly detached from the aluminum foil in water in order to obtain intact pieces of fiber meshes.
The results reflect the average of three electrospun fiber meshes (error bars represent the
standard deviation, SD, for n=3). Each sample was placed into a 50 mL conical centrifuge tube
containing 20 mL water. Since these fibers could have various applications, water was chosen as
the immersion media. Tubes were placed on a shaker (200 rpm, 0.12-inch orbit motion, Thermo
Labline 4625 Titer Shaker, USA) inside an incubator (37C). At predetermined periods of time,
samples were gently taken out of the tubes and moved into new tubes containing 20 mL water
and put back on the shaker at 37C. The time periods of 1 h, 2 h, 4 h, 8 h, 24 h, 3 days, 7 days,
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and 14 days were selected to obtain a time course that reflects potential wound dressing
application periods. Supernatants were analyzed for Ag and Zn using an inductively coupled
plasma mass spectrometer (ICP-MS, Algilent 7900, CA, USA). The released percentages of Ag
at each time interval (Agr) were calculated as follows:
(1)

Where Ags is the mass (g) of Ag measured by ICP-MS in 20 mL supernatants at each
time interval; Agt is the mass (g) of Ag in the original electrospun fiber mesh as calculated by the
mass of Ag that was injected into the inner needle during 1 h of electrospinning (Agt (g) = core
solution feeding rate (mL/h)  electrospinning time (h)  concentration of Ag in the core solution
(g/g)  density of the core solution (g/mL)); As is the sample area (a 15  3 cm2 piece cut out of
the fiber mesh); and At is the original electrospun fiber mesh area (thin edges of fiber meshes
were not included in At). The denominator of formula 1 represents the mass of Ag in the sample
before immersion. The density of the core solution was assumed to be 1 g/mL (density of water)
due to the low concentration of Ag (0.02 Wt% Ag).
The released percentages of Zn were calculated differently since the density of the shell
solution could not be assumed to be 1 g/mL because of complexity of the solution. The released
percentages of Zn at each time interval (Znr) were calculated as follows:
(2)

(3)
Where Zns is the mass (g) of Zn measured by ICP-MS in 20 mL supernatants at each time
interval, Znt is the total mass (g) of Zn in the original fiber mesh. Znt (g) was calculated using
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formula 3 where, Ms is the mass (g) of the sample before immersion; MZnO, MPCL, and MPEG are
the masses of ZnO, PCL, and PEG used for making the fiber mesh, respectively; and Mcore is the
mass of the core solution injected during 1 h of electrospinning. The mass of Zn in the original
fiber mesh (Znt) was calculated as the mass (g) of the sample before immersion (Ms) multiplied
by the mass ratio of ZnO NP to the fiber mesh (formula 3). It was assumed that all of the
solvents were evaporated from the fiber mesh (thus, the denominator of formula 3 represents the
weight of the fiber mesh).
Sample weight loss was determined by measuring the difference between the weight of
samples before and after one and two weeks of immersion in water. Percent weight loss was
calculated using the following formula.

(4)
Where M0 is the sample weight before immersion and Mi is the sample weight after one
or two weeks of immersion. M0 was measured by weighing the sample attached to the aluminum
foil and then subtracting the weight of the aluminum foil.
Electron Microscopy and fluorescent imaging of the fibers
The morphology of the electrospun fiber meshes was evaluated using a field emission
scanning electron microscope (FESEM, Carl Zeiss AG, SUPRATM 55VP) and a scanning
electron microscope (SEM, Hitachi S-4700) in the secondary electron mode. Samples were
coated with gold/palladium prior to imaging. SEM and FESEM were performed on samples
before immersion, and after one- and two- week immersion. Average fiber diameter and pore
size were calculated by measuring at least 150 points of FESEM images using image analyzer
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software (ImageJ, National Institutes of Health, USA). Elemental mapping of the fiber mesh
surfaces was determined using energy dispersive spectroscopy (EDS, TESCAN VEGA3)
performed in conjunction with SEM images.
The core-shell structure of the fibers was further evaluated using a confocal laser
scanning (CLS) microscope (Zeiss LSM 880). For this, fluorescent dextran (FITC–DEAE–
Dextran, 0.01%) was dissolved in the core fluid prior to the electrospinning. The core syringe
and tubing were covered to prevent bleaching of the fluorescent dye. Electrospinning procedures
were performed with the same conditions and fibers were collected directly on cover glasses by
passing the cover glass quickly in front of the spinneret close to the collector. Fibers without
added fluorescent dextran to the core fluid were also collected as the control.
The core-shell structure of the fibers was determined by transmission electron
microscopy (TEM, Hitachi H-7500). A piece of electrospun fiber mesh was embedded in a coldsetting embedding resin (1232 EpofixTM Kit, PA, USA) at room temperature in order to avoid
melting of fibers. Slides of 50 nm thickness were cut from the mounted fiber mesh for the TEM
imaging.
Nitrogen adsorption/desorption analysis
The Brunauer–Emmett–Teller (BET) surface area of samples was measured using
nitrogen physical adsorption method with a gas sorption analyzer (Autosorb iQ-MP,
Quantachrome Instruments, FL, USA). Samples were degassed in vacuum at 30°C for 24 hours
prior to the measurement. BET surface area measurement was performed at International Union
of Pure and Applied Chemistry (IUPAC) standard temperature and pressure (STP) with 52-point
adsorption and 15-point desorption isotherms. Two samples of 1×1 cm2 squares were cut from
the fiber mesh (F-Ag20) and detached from the aluminum foil without any immersion. One
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sample was analyzed without any treatment (before pore formation) and the other sample was
analyzed after one-week immersion in water (after pore formation).
Fourier transform infrared (FTIR) spectroscopy
FTIR spectroscopy was performed on fiber meshes before immersion and after one- and
two-week immersion. FTIR spectra of samples were obtained in the attenuated total reflection
(ATR) mode (Thermo Scientific iD7 ATR accessory for a Nicolet™ iS5 Spectrometer). Dried
pieces of fiber mesh with no additional processing were loaded on the ATR accessory for the
measurement.
X-ray diffraction (XRD) analysis
XRD analysis was performed to assess the crystal structure of fiber meshes before
immersion and after one- and two-week immersion. A PANanalytical X’Pert PRO X-ray
diffractometer was used for XRD analysis. The 2θ range was 10°-50° with a step size of 0.0170°.
X-rays were generated with a Co tube with Fe filter (run at 40 kV and current of 45 mA). XRD
spectra were converted to the spectra recorded by Cu-K using

X'Pert HighScore Plus©

software.
Tensile test
Tensile tests were performed using a Discovery HR2 hybrid rheometer (TA Instruments,
New Castle, DE, USA) at a strain rate of 10 mm/min and with 10N load cell. Fiber meshes were
cut into strips (10  30 mm2) and quickly detached from aluminum foil in water. Samples were
immersed in water (for one and two weeks compared to no immersion) under similar conditions
as used in the nanoparticles release study. Samples were taken out of the water and placed on flat
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tissues to dry. Samples were kept for five days at 20C and 10% humidity prior to the tensile
test. Four replicates were carried out for each measurement. Data is represented as mean ± SD.
Statistical analyses
Statistical analyses were performed using a one- or two-way ANOVA followed by
individual comparison of groups using Holm-Sidak’s multiple comparisons test (PRISM v.7.0,
GraphPad, San Diego, CA, USA). The Holm-Sidak’s multiple comparison results are reported at
supplementary data of chapter 2. A statistical significance level of 5% (p < 0.05) was defined.
The minimum number of replicates was three. Values were reported as M ± SD.
Results and Discussion
Fiber structure
The morphology of fabricated fibers was evaluated via FESEM imaging. Figures 2.1A
and 1B show FESEM micrographs of sample F-Ag20 at 10KX and 30KX magnifications,
respectively. Figure 2.1A reveals the overall morphology of electrospun fibers to be continuous
and randomly aligned. In addition, relatively few beads were detected throughout the fiber mesh
during the FESEM imaging. The average fiber diameter was measured to be 698 ± 529 nm using
ImageJ analyzer software. The fiber diameter distribution is shown in Figure 2.2. Fibers had a
wide diameter distribution of diameters with the majority fiber diameter frequency of 600-800
nm. Figure 2.1B shows the surface of the sample F-Ag20 fibers at higher magnification. Some
microcracks can be seen on the surface of thinner fibers in addition to some dimples on thicker
fibers. These irregular surface features have been suggested to be the result of the phase
separation (between PCL and PEG) during the electrospinning (37). The fiber structure was
sufficient to achieve the controlled delivery goals in this research; however, it is likely that the
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fiber structure could be further improved by using an electrospinning instrument with an isolated
chamber and controlled processing conditions.
Fiber structures of samples F-Ag110 and F-AgMix were similar to the sample F-Ag20
since similar electrospinning conditions were applied in order to avoid creating extra parameters.
Only minor voltage adjustments were applied for electrospinning of samples in order to generate
similar fiber structures. Therefore, data is only shown for sample F-Ag20 and not for samples FAg110 and F-AgMix since they were similar.
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Figure 2.1 FESEM micrographs of fiber mesh F-Ag20: (A) before immersion at 10KX
magnification, (B) before immersion at 30KX magnification (C) after one-week immersion at
30KX magnification, and (D) after two-week immersion at 30KX magnification. F-Ag20 is the
core-shell structured electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
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Figure 2.2 Fiber diameter distribution of fiber mesh F-Ag20 before pore formation. F-Ag20 is
the core-shell structured electrospun fiber mesh containing 20 nm silver nanoparticles in the
core.
Formation of core-shell structure throughout the fibers was evaluated using CLS
microscopy. Figures 2.3A, 2.3B and 2.3C show the fluorescent mode, optical mode and overlay
of the two (fluorescent and optical) images for sample F-Ag20, respectively. The fluorescent
image (Figure 2.3A) represents the core, which contains fluorescent dextran, and is dispersed
throughout the fiber length. The optical mode image (Figure 2.3B) represents the shell part of the
fiber. The overlay image (Figure 2.3C) represents the core-shell structure of the fiber. A discrete
core-shell margin can be seen in the overlay image verifying that no mixing of core and shell
solutions occurred during the electrospinning process. The core and shell diameters changed
when moving the image plane throughout the fiber thickness suggesting a cylindrical fiber shape.
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Moreover, no fiber breaks or core leakage were detected during the CLS microscopic imaging of
the fibers.
In order to verify that none of the materials used for fabrication of fibers had any
background fluorescence, control samples, which contained no fluorescent dextran, were also
imaged. All CLS micrographs of control samples were devoid of any fluorescence in the
fluorescent mode confirming absence of fluorescence background staining (data not shown).
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Figure 2.3 CLS micrographs of a fiber of sample F-Ag20: (A) fluorescent mode image, (B)
optical mode image, and (C) overlay of fluorescent and optical images. F-Ag20 is the core-shell
structured electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
The cross-section of fibers was assessed for more details on the core-shell structure via
TEM microscopy. Figure 2.4 shows a TEM micrograph of a fiber cross-section for sample FAg20. It can be seen in the image that the fibers had a cylindrical core-shell structure. A
discrete, smooth margin could be seen between the core and the shell. No pores could be seen on
the outer surface of the fiber. The dimensions of the core and the shell are shown in Figure 2.4.
The average fiber shell thickness and core diameter measured using ImageJ analyzer software
were 125 ± 17 nm and 547 ± 50 nm, respectively.
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Figure 2.4 TEM micrograph of a fiber cross-section of sample F-Ag20 before pore formation
(100KX, 75KV). Dimensions of the core and the shell are indicated in the image. F-Ag20 is the
core-shell structured electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
EDS micrographs were obtained from the fiber meshes in order to demonstrate that Ag
was loaded inside the core of the fibers throughout the fiber mesh. Ag potentially could leak out
of the core through various defects such as mixing of the core and shell solutions during the
electrospinning, from torn or non-continuous fibers, flawed shell structure, etc. The data in
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Figures 2.5A and 2.5B show the EDS layered image of the fiber mesh F-Ag20 with a surface
area of 340  340 µm2 and its corresponding elemental analysis table, respectively. As can be
seen in the elemental analysis table shown in Figure 2.5B, no Ag was detected on the surface of
the fibers confirming an intact core-shell structure of the fibers throughout the fiber mesh. An
EDS control image was taken of a dried droplet of Ag NP suspension on a piece of aluminum
foil to confirm that Ag in (in the form of Ag NP) can be detected by EDS (data not shown).
Moreover, the red color in the EDS layered image represents Zn. It can be seen that Zn, which is
in the form of ZnO NP, was dispersed all through the fibers’ shell. Other detected elements in the
elemental analysis table are from aluminum foil substrate (Al, Fe), palladium coating (Pd), or the
shell polymer (O).
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Figure 2.5 (A) SEM-EDS image of fiber mesh F-Ag20 before pore formation, and (B) its
corresponding table of elemental analysis, (C) SEM-EDS image of fiber mesh F-Ag20 after pore
formation (two-week immersion), and (D) its corresponding table of elemental analysis. The
color red in the layered SEM-EDS images represents the Zn mapping. F-Ag20 is the core-shell
structured electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
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Pore structure
Improvement of pore structure using ZnO NP
In order to obtain an open pore structure without disturbing the fiber integrity, ZnO NP
were added to the shell simultaneous with the use of PEG as porogen. Our studies showed that a
small percentage of ZnO NP (1.6%) and PEG (7%) successfully resulted in forming pores that
were connected to the core. However, in previous studies high percentage of porogens was
needed to form open pores, which caused rupture/swelling and failure of fiber (10,19,20,38,39).
The data in Figures 2.6A and 2.6B show SEM micrographs of electrospun fibers of samples FPEG and F-Ag20 after pore formation, respectively. The shell composition of sample F-PEG is
different from sample F-Ag20 only in the absence of ZnO NP, i.e. sample F-PEG has no ZnO
NP. Comparing the pore structure of samples F-PEG and F-Ag20 reveals the effect of the ZnO
NP on the pore structure. In sample F-PEG, which only had PEG as the porogen, pores were
shallow and small, while, in sample F-Ag20, which had both PEG and ZnO NP, pores were deep
and large. Therefore, addition of ZnO NP increased the depth and the size of the pores.
Moreover, it can be seen in Figure 2.6B that use of the low percentage of porogens in our studies
resulted in preservation of the shell structure after removal of porogens.
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Figure 2.6 SEM micrographs (30KX, 10KV) of pore structure after one-week immersion of the
fiber meshes: (A) F-PEG (PEG used as porogen) and (B) F-Ag20 (PEG and ZnO used
simultaneously).
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The pore structure during two weeks of immersion was evaluated using FESEM
microscopy. The data in Figures 2.1C and 2.1D show FESEM micrographs of fibers (sample FAg20) after one and two weeks of immersion, respectively. It can be seen that pores were formed
in the fibers with immersion. The data in Figure 2.6B shows the one-week immersed pore
structure at higher magnification. It can be seen that pores did not have a constant diameter going
inward through the fibers. In other words, pores were uneven tunnels through the shell thickness.
Moreover, pores were mostly elongated along the length of fibers and their diameter at the
surface of fibers were measured using ImageJ analyzer software. The pore width (perpendicular
to the fiber length) and length (parallel to the fiber length) diameter distribution are shown in
Figure 2.7. The average pore width and length were measured to be 70 ± 57 nm and 127 ± 64
nm, respectively. Consequently, FESEM results confirmed the formation of mostly oblong pores
in the surface of the fibers.
Moreover, it can be seen in the FESEM micrographs of the immersed fibers (Figures
2.1C and 2.1D) that the intact fiber structure was preserved after one or two weeks of immersion
and no further change in fiber diameter was observed. The measured total weight loss of sample
F-Ag20 after one and two weeks of immersion were 27.9 ± 0.45% and 28.5 ± 0.78%,
respectively. The weight loss during the first week of immersion is most likely due to the pore
formation i.e. dissolution of PEG. The small amount of weight loss during the second week of
immersion (0.6%) is consistent with the FESEM pictures of these fibers (Figure 2.1D) showing
no degradation or loss of fiber integrity during the immersion.
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Figure 2.7 The length and width distribution of the pores formed on the fiber mesh F-Ag20 after
one-week immersion measured from FESEM images using ImageJ software. F-Ag20 is the coreshell structured electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
The changes of fiber mesh surface area due to the pore formation was measured via BET
analysis. The measured surface area and pore volume of sample F-Ag20 before and after oneweek immersion are shown in Table 2.2. The surface area of the fiber mesh had a 5.9-fold
increase after pore formation. The pore volume of fiber mesh had a 6.3-fold increase after pore
formation. These results are consistent with the large number of pores found in the FESEM
imaging of F-Ag20 fibers after pore formation.
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Table 2.2 BET surface area and pore volume measurements of fiber mesh F-Ag20 before pore
formation and after pore formation (one-week immersion). F-Ag20 is the core-shell structured
electrospun fiber mesh containing 20 nm silver nanoparticles in the core.

Before pore formation

After pore formation

Surface area (m2/g)

29.4

173

Pore volume (cm3/g)

0.012

0.076

Figures 2.5A and 2.5C show the EDS layered images of the fiber mesh F-Ag20 before
and after pore formation, and Figures 2.5B and 2.5D show their corresponding elemental
analysis, respectively. It can be seen in both EDS layered images that ZnO NP were dispersed
uniformly throughout the fiber structure both before and after pore formation. Surprisingly,
elemental analysis indicated 9.7 Wt% Zn for fibers before pore formation (Figure 2.5B) and 20.2
Wt% Zn for fibers after pore formation (Figure 2.5D), indicating that a higher amount of Zn was
detected after pore formation.
The higher amount of Zn detected after pore formation suggests two possibilities: first,
ZnO NP were mostly located at the inner part of the shell because EDS collected signals from
deeper parts of the fibers after pores were formed; second, ZnO NP were mostly associated in the
PCL phase rather than the PEG phase because EDS collected more signals from the PCL matrix
after removal of PEG during pore formation. Considering each of these possibilities, two
different mechanisms could explain the deeper pore structure in the presence of the ZnO NP.
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First, during electrospinning, when the fiber jet forms, solvents move toward the surface
of the fibers and evaporate. PEG, which has a lower molecular weight compared to PCL,
migrates with the solvents toward the fiber surface. Therefore, when the phase separation of PCL
and PEG occurs, PCL-rich areas are formed at inner parts of the fibers and PEG-rich areas are
formed at the surface of the fibers. However, when ZnO NP are present, ZnO NP associate with
PEG and hinder the diffusion of PEG. ZnO NP, which are the heaviest components of the shell
solution, may sink into the shell solution and keep the PEG associated deeper in the shell.
Subsequently, pores, which are the emptied spaces formed by selective dissolution of PEG, are
deeper in the presence of ZnO.
Second, association of ZnO NP with the PCL decreases the interfacial energy of the PCL
and PEG phases. Therefore, there is a decreased need for recession of the PEG phase toward the
fiber surface in order to reach a stable energy state, i.e. the PEG phase forms deeper in the fibers.
After removal of the PEG from the PCL matrix via selective dissolution, the phase boundary of
PCL and PEG becomes the pore’s surface area. The lower interfacial energy, i.e. larger phase
boundary in the PCL-ZnO/PEG system is consistent with the high surface area of fibers
measured by BET after pore formation. In addition, the second mechanism can be viewed from
the kinetic of phase separation. During the electrospinning, fast evaporation of solvents (i.e.
concentration changes) results in a phase separation of the porogen and the shell polymer. The
fast evaporation of solvents (in the range of milliseconds) favors spinodal phase separation rather
than binodal phase separation, which results in matrix-dispersed phase morphologies rather than
co-continuous. Therefore, closed or shallow pores form by removal of the porogen (40,41).
However, presence of ZnO NP could alter the kinetic toward binodal phase separation, which
allows for coarsening of the PEG phase. Therefore, open or deep pores form by removal of PEG.
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Either or both of these mechanisms could result in the pore depth increase. However, the
second mechanism could be more prevalent since no burst release of ZnO NP was seen in this
study, i.e. not many of ZnO NP were associated with PEG, which dissolves within the minutes of
immersion in water (42). Further studies are needed to determine the effects of ZnO
nanoparticles on the phase separation PCL/PEG during the electrospinning process.
Release of nanoparticles
Release of Ag
In order to fine-tune the Ag NP release rates, fibers were loaded with 20 nm Ag NP, 110
nm Ag NP, and a mixture of the two Ag NP in their core. A two-week release study was
performed to evaluate the release profile of Ag (in the form of nanoparticles and/or ion) from the
fiber meshes. Fiber meshes were immersed in water (shaking at 37°C) and water samples were
collected and analyzed using ICP-MS for the presence of Ag at the predetermined time intervals.
Shorter time intervals were chosen for the first day of the release study in order to investigate the
presence of the burst release stage in the release profile. Burst release is an initial fast release of
the drug in the early stage of the drug delivery before reaching a stable release rate (43).
Burst release stage: The Ag release profile during the first 8 hours of immersion is
shown in Figure 2.8A. A burst release of Ag can be seen at one hour of immersion for all three
samples. The burst release seen in such core-shell electrospun fibers is thought to be due to the
fast release of a part of the drug that is located close to the surface of the fibers, after a fast
dissolution of PEG (44). During the burst release stage (first hour), samples F-Ag20, F-Ag110,
and F-AgMix released 28%, 24%, and 33% of Ag, respectively. According to the EinsteinStokes equation, diffusion coefficient is inversely related to the particle size (45). Therefore, it
was expected that the 20 nm Ag NP would release the fastest, 110 nm Ag NP would release the
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slowest, and the mixture of these two Ag NP would have an intermediate release rate (46).
However, the amount of released Ag observed at the burst release stage was not related to the
size of the Ag NP loaded inside the fibers. The amount of released Ag during the primary stage
was the lowest for F-Ag110, which is in accordance with the slower diffusion of larger Ag NP
from the fibers. This result suggests that a larger size of Ag NP loaded in fibers could reduce the
burst release. The Ag release rate at the burst release was fastest for F-AgMix, in contrast to the
expectation that the 20 Ag NP (sample F-Ag20) would release fastest. In addition, it should be
noted that the differences in the burst release rate of the different samples were not large.
We propose that the Ag burst release rate was related to the quality of the fibers (number
of beads and homogeneity of fibers). The higher burst release from fiber meshes with lower fiber
quality could be because Ag NP located at the site of the inhomogeneity and beads release faster
due to the thinner shell (shorter diffusion distance), higher number of Ag NP (higher
concentration gradient) and more core fluid (higher flow velocity) (45). This hypothesis is
consistent with the SEM assessment revealing the lowest fiber quality for F-AgMix, compared to
the samples F-Ag20 and F-Ag110. This result implies that the burst release stage was affected by
the uncontrolled environmental condition of the electrospinning in this study. We suggest that
using an electrospinning instrument with an isolated chamber and controlled environmental
condition would result in a reduction of the Ag burst release.
Sustained release stage: The Ag release profile of the samples during the two-week
immersion period is shown in Figure 2.8B. It can be seen in Figure 2.8B that after the burst
release, all samples enter a second stage of sustained Ag release for the rest of the immersion
period (two weeks). During the second stage, samples F-Ag20, F-AgMix, and F-Ag110 released
51%, 29%, and 12% of Ag NP mass, respectively. The cumulative Ag release after two weeks of
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immersion was 79%, 62%, and 36% for samples F-Ag20, F-AgMix, and F-Ag110, respectively.
The amount of released Ag and the slope of the release curves were inversely related to the size
of Ag NP, i.e. smaller Ag NP had a faster release rate. The size of Ag NP was the only difference
between the compositions of these three samples. The shell pore size (diffusion path) was kept
constant in all samples by using the same amount of PEG and ZnO in the shell solution, in
addition to equivalent electrospinning procedures. Therefore, it can be concluded that the size of
Ag NP was the controlling factor for the diffusion of Ag NP out from the fiber core and through
the shell. The 20 and 110 nm Ag NP had fast and slow diffusion rates through the pores,
respectively. These results suggest that various release rates of the Ag NP (or possibly, any other
drug in the form of nanoparticles) can be obtained by altering the size of the applied Ag NP.
Moreover, simultaneous use of 20 and 110 nm Ag NP resulted in an intermediate release rate,
suggesting that a summative release rate can be obtained by simultaneous use of Ag NP with
various sizes.
It is possible that the Ag release is in the form of ion rather than nanoparticles. However,
according to a study performed by Wang et al (47) for measuring the dissolution rate of 30 nm
Ag NP of a similar brand and citrate coating, the dissolution rate of the 20 nm Ag NP used in our
study should be in the range of 0.14 µg/mL after two weeks of immersion. The cumulative
amount of Ag released from F-Ag20 fiber meshes was measured to be 17 µm/mL (79%) after
two weeks of immersion, which is much higher than 0.14 µg/mL. Therefore, it can be concluded
that the release mechanism of Ag was mainly by diffusion of Ag NP through the pores located in
the shell. In other words, the dissolution of Ag NP and diffusion of Ag ions had a negligible
effect on the release results. Moreover, the dissolution rate is even lower for 110 nm Ag NP, due
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to their lower surface area, compared to 20 nm Ag NP. Hence, the dissolution of 110 nm Ag NP
and its ion diffusion should not be considered as an effective release mechanism.

Figure 2.8 Percent cumulative release of Ag from fiber meshes of F-Ag20 (●), F-Ag110(▲),
and F-AgMix (X) during immersion: (A) first 8 hours and (B) two weeks. Error bars represent
standard deviation of three measurements. F-Ag20, F-Ag110, and F-AgMix are the core-shell
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structured electrospun fiber meshes containing 20 nm, 110 nm, and a mixture of both silver
nanoparticle sizes in the core, respectively.
Release of Zn
The amount of Zn released in water from the fiber meshes was measured in addition to
the Ag in the release study. The cumulative release profile of Zn during two weeks of immersion
is shown in Figure 2.9. The Zn release profile was similarly slow and sustained in all samples
and showed no significant difference (the error bars overlap). The ZnO NP associated to the PEG
phase were anticipated to be released in the early stage of immersion period by the fast
dissolution of PEG in water. However, no burst release was seen in the release profile of Zn,
implying that most of ZnO NP were associated with the PCL phase of the fiber shell. The higher
association of ZnO NP with PCL was also supported by the EDS elemental mapping results
(Figure 2.5D) showing a higher weight percentage of Zn on the surface of fibers after two weeks
of immersion (when PEG was removed from the shell), compared to non-immersed fibers
(Figure 2.5B).
Leaching or desorption of ZnO NP exposed on the surface of fibers is suggested to be the
release mechanism of Zn (48). Shell composition and structure of fibers were similar for samples
F-Ag20, F-Ag110, and F-AgMix, resulting in similar condition for Zn release from the fiber
shell. This was confirmed by the similar Zn release rate in all fiber meshes during two weeks of
immersion. The cumulative release of Zn was about 14% after two weeks of immersion, which
was slower than the Ag release due to the different release mechanisms i.e. Ag NP diffuse
through the pores located in the shell, while Zn ions leach out of the shell matrix (PCL phase).
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Figure 2.9 Percent cumulative release of Zn from fiber meshes of F-Ag20 (●), F-Ag110(▲),
and F-AgMix (X) during two weeks of immersion. Error bars represent standard deviation of
three measurements. F-Ag20, F-Ag110, and F-AgMix are the core-shell structured electrospun
fiber meshes containing 20 nm, 110 nm, and a mixture of both silver nanoparticle sizes in the
core, respectively.
Molecular structure
The surface functional groups of fiber meshes before immersion and after one- and twoweek immersion were assessed using FTIR analyses (Figure 2.10). The band seen at 1722 cm-1 is
related to the C=O stretching of ester carbonyl group. A small decrease was seen in the band at
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1722 cm-1 after one- and two-weeks immersion. Decreases seen in the C=O stretching of the
PCL suggest an interaction between the PCL carbonyl groups and ZnO NP. (This interaction
could be a physical interaction due to Vander Waals forces (49).) A suggested schematic to
explain this interaction is shown in Figure 2.11 (49). The suggested interaction is consistent with
the decrease seen in the broad 400-700 cm-1 band, which is related to stretching of the Zn-O
bond. During immersion, polymer chains can move and interact with ZnO NP. The decrease of
Zn-O bond intensity is larger for the one-week immersion, compared to the two-week
immersion. This shows a better interaction of ZnO-PCL after one week and its subsequent
weakening after two weeks of immersion.

Figure 2.10 FTIR spectra of fiber mesh F-Ag20: before immersion (——), one-week immersed
(— —), and two-week immersed (- - -). F-Ag20 is the core-shell structured electrospun fiber
mesh containing 20 nm silver nanoparticles in the core.
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Figure 2.11 Schematic presentation of ZnO NP and PCL polymer chain interaction (adapted
from (49)).
Crystal structure
The effect of immersion on the crystal structure of electrospun fibers was studied by
XRD. Figure 2.12 shows the XRD diffractograms of non-, one- and, two-week immersed FAg20 fiber meshes. Three peaks at 21.4°, 22° and 23.7° seen on all three diffractograms
correspond to (110), (111) and (200) planes of PCL orthorhombic crystal structure, respectively
(50). The intensity of these three peaks are the lowest for non-immersed fibers, showing the
lowest crystallinity of PCL in the fibers without immersion. While, after one week of immersion,
the intensity of PCL peaks (21.4°, 22° and 23.7°) increased, showing an increase in PCL
crystallinity. The explanation for the lowest intensity of PCL peaks for non-immersed fibers
could be that during electrospinning, mobility of the polymer chains is restricted by the presence
of ZnO NP, as well as, fast evaporation of solvents, resulting in a lower crystallinity (49).
However, the higher intensity seen after one-week immersion suggests an annealing effect of
immersion at 37°C for the polymer chains to reorient into higher crystallinity state (lower energy
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state). The immersion temperature of 37°C is higher than the glass transition temperature of PCL
(-60°C), in which PCL polymer chains have higher mobility.
The intensity of the PCL peaks (21.4°, 22° and 23.7°) had small decreases after two
weeks of immersion, relative to one-week, although the intensity was still higher for the twoweeks immersed samples compared to non-immersed samples. This decrease could be due to the
start of degradation of PCL after two weeks of immersion.
Two peaks at 19.2° and 23.3° seen in the XRD diffractograms of non-immersed fibers
correspond to the PEG. The PEG peak at 23.3° has an overlap with the PCL peak at 23.7°. The
PEG peak at 19.2° was eliminated from the XRD diffractograms of one- and two-week
immersed samples showing that during immersion, PEG was extracted from the fibers by
dissolving in water. However, the intensity of the PCL and PEG overlapping peak at 23.7°
increased in the one- and two-week immersed fibers. The increase in the intensity of peak 23.7°
occurred simultaneously with the increase of the two other PCL peaks at 21.4° and 22°.
Therefore, the intensity increase seen in the peak at 23.7° is related to the increase of PCL
crystallinity, which has compensated for the loss in the intensity of the peak at 23.3° due to the
removal of PEG from the structure.
In the XRD diffractograms of non-immersed fibers, three peaks at 31.8°, 34.4° and 36.3°
correspond to (100), (002) and (101) planes of ZnO wurtzite crystal structure, respectively.
These three peaks are lost from XRD patterns of the fibers after immersion. In addition, a peak
has appeared at 12.9° on the XRD patterns of the fibers after one- and two- weeks immersion,
which is related to Zn5(OH)8(CH3COO)2.2H2O (51). This result shows an interaction of Zn with
oxygen of the ester bond in the PCL molecular chains, which is consistent with the FTIR spectral
results.
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Figure 2.12 XRD diffractograms of fiber mesh F-Ag20: before immersion (——), one-week
immersed (— —), and two-week immersed (- - -). F-Ag20 is the core-shell structured
electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
Mechanical properties
Tensile studies were conducted to determine the stability of the fiber meshes after
immersion. The stress-strain curves of the fiber meshes before immersion and after one- and
two-week immersion are presented in Figure 2.13. The average elongation at break, ultimate
tensile strength, and Young’s modulus obtained for four samples are presented in Table 2.3. The
average elongation at break of fibers increased 115% and 76% after one- and two-week
immersion, respectively. In addition, the average tensile strength of fibers increased 59% and
16% after one- and two-week immersion, respectively. Finally, the average Young’s modulus of
fibers decreased 6% and 44% after one- and two-week immersion, respectively.
The unexpected observed improvement of mechanical properties following immersion
could be due to the removal of residual stresses by an annealing effect of immersion. Residual
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stresses are created in the fibers due to two simultaneous factors. First, during the electrospinning
process, solvents evaporate in a fraction of second not allowing enough time for polymer chains
to move. Consequently, polymer chains rapidly solidify (or freeze) into a high energy, metastable
phase (52). Second, deformation caused by the whipping motion of the polymer solution jet
during electrospinning applies stress onto the polymer chains. Subsequently, when fiber meshes
are immersed at 37°C, polymer chains can move and reorient to a state with lower energy, which
is the crystalline phase. The annealing process is also facilitated by the plasticizing or lubricating
effect of water. The presence of water molecules between the polymer chains helps the polymer
chains to slip past each other (1,53). This hypothesis is consistent with the XRD results showing
an increased crystallinity of PCL after one- and two-week immersion.
The annealing process can also increase the tensile strength by improving the interface of
the reinforcement (ZnO NP) and the polymer matrix (PCL) (54), which is consistent with the
FTIR results showing an improvement of ZnO-PCL interactions. The high increase of
mechanical properties suggests that both these mechanisms (increase of PCL crystallinity and
improvement of ZnO-PCL interaction) occurred during the immersion.
Further studies are needed to fully evaluate the molecular structure and mechanical
property changes occurring in the individual fibers during immersion. In general, there are not
many studies reporting changes of fiber’s mechanical properties with immersion. Some studies
report that mechanical properties deteriorate with immersion, which is suggested to occur due to
degradation of polymer (50,55,56). However, other studies have reported increases of the
Young’s modulus (50,56), tensile strength (50,55), elongation at break (55,57,58), or impact
energy (59) with water immersion. The plasticizing effect of water was suggested to be
responsible for improvement of plasticity in those studies (55,59).
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Figure 2.13 Tensile stress-strain curves of fiber mesh F-Ag20: before immersion (——), oneweek immersed (— —), and two-week immersed (- - -). F-Ag20 is the core-shell structured
electrospun fiber mesh containing 20 nm silver nanoparticles in the core.
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Table 2.3 Measured tensile properties (elongation at break, ultimate tensile strength, and
Young’s modulus) of non-, one-, and two-week immersed fiber mesh F-Ag20. The SD for n=4 is
reported in the parentheses for each measurement. F-Ag20 is the core-shell structured
electrospun fiber mesh containing 20 nm silver nanoparticles in the core.

Non-immersed
One-week
immersed
Two-week
immersed

Elongation at

Ultimate Tensile

Young’s

Break (%)

Strength (KPa)

Modulus (KPa)

41.33 (6.58)

919.46 (72.99)

88.56 (1.62)

89.10 (12.36)

1466.55 (123.23)

83.40 (18.52)

72.79 (4.11)

1067.60 (53.77)

49.37 (2.43)

Conclusions
The main achievement of this research was forming deep discrete pores in the fiber shell
using ZnO NP to control the delivery rate of therapeutic agents. The delivery rate was fine-tuned
via loading different sizes of Ag NP inside the core of coaxial electrospun fibers. This research
showed that fast, intermediate, and slow delivery of drug could be achieved by using different
sizes of Ag NP. Moreover, it was shown that preserving the mechanical stability of the fibers
using ZnO NP prevented the sudden uncontrolled release of the drug seen in previous studies
(19,20).
The major advantage of this novel use of diffusion to control the drug delivery rate is its
flexibility for using any type of drug from antibiotics, to growth factors, to cancer drugs. These
drugs could be produced in the form of nanoparticles or could be loaded on the surface of carrier
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nanoparticles. Moreover, the presented drug delivery method described in this study could be
applied for delivery of bioactive agents, such as bacteriophages, since the agent is loaded inside
the fiber core and is preserved from the organic solvents used in the shell or from the harsh
conditions of electrospinning. Another possible application of this delivery method, is
simultaneous delivery of several therapeutic agents and individual control of their delivery rates
via modification of the size of the nanoparticles.
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Supplementary data of chapter 2
Table 1. The Holm-Sidak's multiple comparisons test results for the percent cumulative
release of Ag from fiber meshes reported in Figure 2.8B. Asterisks indicate significant difference
****p < 0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
F-Ag20 vs. F-AgMix

F-Ag20 vs. F-Ag110

F-AgMix vs. F-Ag110

1h

ns

ns

*

2h

ns

ns

**

4h

*

ns

***

8h

***

ns

****

24h

****

ns

****

72h

****

ns

****

168h

****

***

****

336h

****

****

****
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Table 2. The Holm-Sidak's multiple comparisons test results for the percent cumulative
release of Zn from fiber meshes reported in Figure 2.9. Asterisks indicate significant difference
****p < 0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
F-Ag20 vs. F-AgMix

F-Ag20 vs. F-Ag110

F-AgMix vs. F-Ag110

1h

ns

ns

ns

2h

ns

ns

ns

4h

ns

ns

ns

8h

ns

ns

ns

24h

ns

ns

ns

72h

ns

ns

ns

168h

ns

ns

**

336h

ns

ns

****

Table 3. The Holm-Sidak's multiple comparisons test results for the measured tensile
properties (elongation at break, ultimate tensile strength, and Young’s modulus) of non-, one-,
and two-week immersed fiber mesh F-Ag20 reported in Table 2.3. Asterisks indicate significant
difference ****p < 0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
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Non-immersed vs.

Non-immersed vs.

one-week immersed vs.

one-week immersed

two-week immersed

two-week immersed

Elongation at break

**

**

ns

Ultimate tensile strength

***

ns

**

Young's modulus

ns

*

*
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Chapter 3: Electrospun fibers loaded with
ball-milled microgel particles for smart
delivery applications
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Abstract
Stimuli-responsive electrospun fibers loaded with therapeutic agents for smart delivery
triggered by stimuli such as temperature or pH are attractive options for wound dressing, cancer
treatment, and tissue engineering applications. However, development of such fibers requires the
use of complex chemical processes that can induce toxicity, reduce fiber quality, or prohibit fiber
electrospinnablity. To address these challenges, core-shell structured fibers capable of
temperature-controlled delivery of nanoparticles were developed. The fiber core contained an
aqueous suspension of poly(n-isopropylacrylamide) (PNIPAM) microgel particles and silver
nanoparticles (Ag NP, as a model antibacterial drug). A novel use of ball-milling was applied to
produce microgel particles with an average hydrodynamic diameter of 511 ± 100 nm. The ballmilling technique was developed to avoid the current complex chemical processes for syntheses
of microgels, and to address the need for high-yield techniques in industrial manufacturing. The
results show that the thermoresponsive properties of the PNIPAM hydrogel particles were
preserved during the ball-milling process. The fiber shell formed a strong and ductile structure
matrix, regulated the nanoparticles release pathway (through stable and defined pores formed via
selective dissolution of porogen), in addition to serving as a barrier to prevent direct contact of
the microgel particles with tissues. This core-shell fiber design allows for the future application
of various therapeutic agents, including fragile and bioactive agents, and microgel particles with
special properties.
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Temperature controlled release of silver nanoparticles from core-shell structured electrospun
fibers via application of poly(n-isopropylacrylamide) microgel particles inside the core
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Introduction
Stimuli-responsive polymers are called “smart” polymers for the ability to sense and
respond to environmental parameters such as temperature, light, pH, and electromagnetic force
(1,2). In particular, poly(n-isopropylacrylamide) (PNIPAM) is a thermoresponsive polymer with
a reproducible lower critical solution temperature behavior. PNIPAM has been extensively
studied for development of various drug delivery systems owing to its transition temperature
being close to the human body temperature (between 30 to 35, depending on the solvents and
chain modifications) (3,4). Therapeutic agents can be incorporated with the polymer in the
swollen hydrophilic state below the transition temperature and released in the collapsed
hydrophobic state on demand when the ambient temperature increases above the transition
temperature (5,6). Therefore, to improve the treatment efficacy, various PNIPAM drug delivery
systems in the form of fibers, microgels, and films are developed (7–10).
Electrospun fibers of PNIPAM are highly attractive for biomedical applications such as
wound dressing, tissue engineering and cancer treatment (10–12). However, several challenges
have hindered their use in such applications. The primary shortcoming of PNIPAM electrospun
fibers is the lack of mechanical stability caused by dissolution of PNIPAM below the transition
temperature and collapse of the polymer network above the transition temperature (13,14).
Therefore, the low mechanical stability of PNIPAM fibers can result in a burst release of loaded
drugs, possible toxic effects of fast released polymer or loaded drug, and failure to deliver
required mechanical support (15–19). Cross-linking of the PNIPAM polymer network could
stabilize the PNIPAM fibers (20–23). However, crosslinking must be performed after the
electrospinning process because it is not possible to inject a crosslinked polymer, which is
solidified, through the spinneret. While post-crosslinking is effective to improve the mechanical
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stability of the fibers, it precludes the possibility of loading fragile or bioactive therapeutic
agents into the fibers because of the harsh conditions and organic solvents required for
crosslinking (24–26).
Smart microgel particles (including PNIPAM microgels) are crosslinked polymer
particles that have a stimuli-responsive property (27). Due to the smaller dimension, the
swelling/deswelling response of microgel particles is much faster than macroscopic hydrogels
(28). Accordingly, microgel particles have prompted great interest in a variety of applications
such as biomedical applications, filtration, and nanoreactors (29–32). In particular, biomedical
and cosmetic applications require mechanical and chemical versatility of microgels, along with
biocompatibility. Therefore, there is a great need for novel design strategies that can
simultaneously meet the biological and physical attributes of microgel particles (33–35).
Importantly, the increasing industrial applications of microgel particles, such as the agriculture
and food industry, demand large scale manufacturing techniques (36–38).
In the current study, electrospun fibers with a core-shell structure were designed to
simultaneously address challenges of mechanical stability, burst release, possible toxicity, and
capable of loading bioactive or fragile therapeutic agents. Unlike other fiber designs where the
whole fiber or fiber shell were electrospun from PNIPAM, we used PNIPAM microgel particles
and loaded them inside the fiber core. The fiber core contained a suspension of PNIPAM
microgel particles and silver nanoparticles (Ag NP), which were used as a model antibacterial
drug. We also developed a novel use of ball-milling as a simple, non-toxic, and high-yield
technique for producing microgel particles. The use of ball-milling was developed to avoid the
current chemical complexities for synthesizing microgel particles, which usually require the use
of toxic chemicals (24).
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Materials and methods
N-isopropylacrylamide (NIPAM, ≥99%), potassium persulfate (ACS reagent, ≥99.0%),
Tetramethylenediamine (TEMED, 99%), Poly(ethylene glycol) (PEG, BioUltra, Mw = 3,350
g/mol), polycaprolactone (PCL, MW = 45,000 g/mol), Chloroform (biotechnology grade,
≥99.8%, 0.5-1.0% ethanol as stabilizer), N,N-Dimethylformamide (DMF, ReagentPlus, ≥99%),
and fluorescein isothiocyanate-diethylaminoethyl-dextran (FITC–DEAE–Dextran, Mw = 70,000
g/mol) were purchased from Sigma-Aldrich, USA. Laponite XLG was provided by BYK
Additives Inc., Gonzales, TX, USA. Citrate coated silver nanoparticles (Ag NP, 20 nm diameter,
1 mg/mL) stabilized in 2 mM sodium citrate aqueous solution were obtained from
NanoComposix (BiopureTM, San Diego, CA, USA). Zinc oxide nanoparticles were obtained from
Meliorum Technologies, Inc. (ZnO NP, 20 nm diameter, Rochester, NY, USA). Characterization
information of ZnO NP and Ag NP is available in our previous studies (39,40). Ultrapure Mili-Q
water, obtained from a Milli-Q water purifier (QGARD00D2, Millipore, USA), was used
throughout this study.
Preparation of the PNIPAM microgel particles (microgel)
PNIPAM hydrogel was synthesized via an in situ free radical polymerization method
developed by Haraguchi, k. et al (41). Laponite XLG clay (1 g) and n-isopropylacrylamide (3 g,
NIPAM) were added into water (28.5 mL) and stirred in a round bottom flask while bubbled
with nitrogen gas for three hours at 20°C. Afterward, the temperature of the solution was brought
to 0°C using an ice bath, and a solution of the catalyst (TEMED, 24 µL) and initiator (KPS, 0.03
g) in water (1.5 mL) was injected into it. The ice bath was then allowed to reach room
temperature (20°C) and free radical polymerization was allowed to proceed for 20 hours. The
positive pressure of nitrogen was maintained inside the reactor during the whole polymerization
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process to avoid oxygen. The prepared hydrogel was then cut into small pieces (~ 1 cm3) and
soaked in water for 48 hours (water was changed several times) to purify the hydrogel. After
purification, the hydrogel pieces were dried at 40°C for 48 hours. Afterward, 3.6 g of the dried
hydrogel pieces were put in a ball-mill vial and ball-milled with 4 balls for 80 minutes. Ballmilling was performed using a zirconia ceramic grinding vial set (6.35 cm × 6.8 cm, 8005),
zirconia ceramic balls (12.7 mm diameter, 8005A), and a mill (8000D DUAL MIXER/MILL®)
obtained from SPEX® SamplePrep, Metuchen, NJ, USA.
Preparation of PNIPAM microgel particles with Ag NP
To make the suspension of PNIPAM microgel particles (3 Wt%) and Ag NP (0.01 Wt%),
the ground microgel (0.3 g) was added into water (9 mL) and stirred for 4 hours. The suspension
was then pushed through a 25-gauge needle to break up any agglomerates of microgel particles.
Afterward, an aqueous suspension of Ag NP (1 mL) was added to the microgel particles
suspension, and the final suspension was stirred overnight before the electrospinning process.
Electrospinning of core-shell fibers
The core-shell fibers were fabricated using a coaxial electrospinning instrument designed
and constructed in our laboratory. The electrospinning instrument was housed inside an
electrically-insulated plastic case that was inside a laboratory safety hood (ambient humidity
10% and room temperature 20°C). The electrospinning arrangement was horizontal and the
spinneret to collector distance was 14 cm. A prebuilt blunt coaxial spinneret (100-10COAXIAL-2016, ramé-hart instrument Co.) with a 16-gauge outer needle and a 20-gauge inner
needle was used. The collector was a rotating drum (226 rpm, 5.08 cm diameter) which was
covered with a piece of aluminum foil. The spinneret was connected to DC power (17 kV) and
the collector was grounded. An optimum fiber structure was achieved in this study using a shell
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composition of 14 Wt% PCL, 6.5 Wt% PEG, and 1.6 Wt% of ZnO NP in a mixture of
chloroform and DMF (with a ratio of 17:10), and core composition of 3 Wt% PNIPAM microgel
particles and 0.01 Wt% of Ag NP in water. The core and shell fluid feeding rates were 0.4 and 1
mL/h, respectively. Fiber meshes were obtained during one hour of electrospinning, then left
inside the hood to dry overnight. The electrospun fiber mesh was designated F-AgHG
representing the Ag NP and PNIPAM microgel particles inside the fiber core.
Dynamic Light Scattering (DLS)
DLS measurements were performed to evaluate the swelling/shrinking behavior and
particle size changes of the PNIPAM microgel particles in water using a Zetasizer Nano ZS
(Malvern Instruments Ltd., ZEN3600, UK). The hydrodynamic diameter of microgel particles
was measured over the temperature range of 20-50°C with temperature intervals of 1°C (three
measurements were performed at each temperature interval). The concentration of the microgel
particles in water was adjusted to prevent particle-particle interaction due to the agglomeration,
and obtain count rate (photons detected per second) higher than 10 KCPS (kilo-counts per
second) (42,43).
Differential Scanning Calorimetry (DSC)
DSC measurements were performed to determine the thermoresponsive phase transition
of the PNIPAM microgel using a TA differential scanning calorimeter (Q20 V24.11 build 124,
USA). After synthesizing the PNIPAM hydrogel and purifying it by soaking in water, a small
piece (6.21 mg) of the PNIPAM hydrogel was cut and put in a Tzero aluminum hermetic pan and
scanned over a temperature range of 25-50°C with the heating rate of 3°C/min, under nitrogen
atmosphere. Microgel particles obtained by ball-milling were also tested; a 3 Wt% suspension of
PNIPAM microgel particles (6.24 mg, preparation explained in part 2.3) was pipetted into a
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Tzero aluminum hermetic pan and was scanned under a similar condition. The 3 Wt%
concentration was chosen because it is the concentration of the PNIPAM microgel particles in
the fiber core.
Release of nanoparticles
Rectangular samples of 15 cm  3 cm were cut from the center of electrospun fiber
meshes. To obtain intact sample pieces, fiber meshes were dipped in water for a few seconds and
then quickly detached from the aluminum foil on which they were electrospun. Samples were
placed into 50 mL conical centrifuge tubes filled with 20 mL of water. The tubes were placed on
shakers (200 rpm, 0.3-cm orbit motion, Thermo Labline 4625 Titer Shaker, USA) on a lab bench
(room temperature of 20°C) or inside an incubator (37°C). At predetermined time intervals,
samples were gently taken out of the tubes and transferred into new tubes filled with 20 mL fresh
water and put back on the shakers. The time intervals of 1 h, 2 h, 4 h, 8 h, 24 h, 3 days, 7 days,
and 14 days were selected to determine the short and long-term use of fiber meshes. Water was
chosen as the immersion media to consider possible uses of the fibers for various applications
ranging from biomedical to filters and sensors (10,11). The average of three samples was used
for each data point (error bars represent the standard deviation, SD, for n=3). The amounts of Ag
and Zn released in the supernatants were measured using an inductively coupled plasma mass
spectrometer (ICP-MS, Agilent 7900, CA, USA). The released percentages of Ag at each time
interval (Agr) were calculated as follows:
(1)

Where Ags is the measured Ag (g) by ICP-MS in 20 mL supernatant at each time
internal; Agt is the primary amount of Ag (g) injected into the inner needle during 1 h of
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electrospinning; As is the cut sample area (15 cm × 3 cm); and At is the primary area of the
electrospun fiber mesh.
The released percentages of Zn at each time interval (Znr) were calculated as follows:
(2)

(3)
Zns is the measured Zn (g) by ICP-MS in 20 mL supernatants at each time interval; Znt is
the total Zn (g) in the primary electrospun fiber mesh. Znt was calculated using formula 3 where,
Ms is the mass (g) of the sample before immersion; MZnO, MPCL, and MPEG are the masses of
ZnO, PCL, and PEG used for making the fiber mesh, respectively; and Mcore is the mass of the
core solution injected during 1 h of electrospinning. A more detailed explanation of formulas 1-3
can be found in our previous study (44).
Weight loss of fiber meshes
The F-AgHG samples of the release study were weighed before immersion and after oneand two-week immersion at 20°C and 37°C to calculate their weight loss. The percent of sample
weight loss was calculated as follows:

(4)
Where M0 is the sample weight before immersion and Mi is the sample weight after oneand two- week immersion at 20°C or 37°C.
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Tensile test
Samples were prepared by cutting the fiber meshes into strips of 1 cm × 7 cm. Then fiber
samples were quickly detached from the aluminum foil in water to avoid damage. Samples were
then immersed in 15 mL water for one and two weeks on shakers (200 rpm, 0.12-inch orbit
motion, Thermo Labline 4625 Titer Shaker) placed at 20°C and 37°C. The no immersion group
was air-dried after detachment from the aluminum foil. All samples were kept for four days at
20°C and 10% humidity (laboratory ambient condition) before the tensile test. Tensile tests were
performed at strain rate of 10 mm/min and load cell of 10 N using a Discovery HR2 hybrid
rheometer (TA Instruments, New Castle, DE, USA). The gauge length was set at 30 mm and the
gripping distance was 10 mm. The thickness of fiber meshes was measured with FESEM
imaging. Four replicates were performed for each measurement.
PNIPAM microgel particles release
Similar to the release study, fiber meshes cut into rectangular samples of 15 cm × 3 cm
were immersed in 20 mL water with shaking at 20°C and 37°C for two weeks. After two weeks
of immersion, fiber meshes were removed and water samples were collected. Water samples
were centrifuged at 9,000  g for 3 minutes at 20°C to pellet any fiber mesh pieces that might
have degraded during the immersion. We confirmed that using this centrifugation procedure did
not pellet any detectable PNIPAM microgel particles. As a control, a suspension of the PNIPAM
microgel particles in water with a known concentration was centrifuged and placed at 50°C to
visualize the PNIPAM microgel particles (which are opaque above the transition temperature).
To increase the detection limit of the PNIPAM microgel particles in water samples, the
concentration was increased 3-fold by centrifugation at 15,000  g for 10 minutes at 40°C to
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pellet PNIPAM microgel particles. Then, 2/3 of the water was pipetted out to increase the
concentration. The concentrated water samples were then cooled to 20°C and the PNIPAM
microgel particles were resuspended by vortexing. Then, 200 µL of the water samples were
pipetted into 96 microwell plates, and measuring the optical density at 450 nm (OD450,
SpectraMax M4 multi-mode microplate reader, Molecular Devices, USA) was used to determine
the amount of PNIPAM microgel particles released after two-week immersion. The OD450 was
measured at 50°C because the PNIPAM microgel particles are opaque and absorb light above the
transition temperature, thus they can be detected at lower concentrations. The detection limit of
the PNIPAM microgel particles in aqueous suspension was determined by making a
concentration series of the suspensions and measuring their OD450 at 50°C.
Scanning electron microscopy and fluorescent imaging
Scanning electron microscope (SEM, Hitachi S-4700) imaging was used to assess the
morphology and the size of ball-milled microgel particles. A small amount of the ground
PNIPAM microgel particles was placed on a carbon taped stage and then gold-coated for
imaging. Field emission scanning electron microscope (FESEM, Zeiss SUPRA 55VP) imaging
was used to determine the morphology of electrospun fiber meshes before and after immersion
(one and two weeks). Fiber meshes were gold-coated before imaging. At least 200 points of
FESEM images were measured using image analyzer software (ImageJ, National Institutes of
Health, USA) to calculate the average fiber diameter and pore size.
Confocal imaging (Confocal Laser Scanning Microscope, CLS, Zeiss LSM 880) was
used to assess the core-shell structure of the fibers. Fluorescent dextran (FITC_DEAE-Dextran,
0.01%) was added to the core fluid and protected from light to avoid photobleaching.
Electrospinning procedure was performed with similar conditions and fibers were collected on a
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microscopy cover glass quickly passed in front of the spinneret close to the collector. Fibers
without fluorescent dextran were also collected as a control.
Statistical analyses
Statistical analyses were performed using a one- or two-way ANOVA followed by
individual comparison of groups using Holm-Sidak’s multiple comparisons test (PRISM v.7.0,
GraphPad, San Diego, CA, USA). The Holm-Sidak’s multiple comparison results are reported at
supplementary data of chapter 3. A statistical significance level of 5% (p < 0.05) was defined.
The minimum number of replicates was three. Values were reported as M ± SD.
Results and discussion
Characterization of the PNIPAM microgel particles
A novel method of producing microgel particles was developed to avoid the current
chemical challenges in synthesizing microgel particles for use in electrospun fibers. PNIPAM
microgel particles produced via this method were first characterized to make sure that the drying
and ball-milling did not interfere with the function of the hydrogel i.e. thermoresponsive
behavior, and also that particles have an appropriate size to be loaded inside the fiber core via
coaxial electrospinning.
SEM imaging was performed to characterize the general morphology of microgel
particles after ball-milling (in the dry state). Figures 3.1A and 3.1B show the microgel particles
at two different magnifications. It can be seen in these micrographs that the microgel particles
had irregular shapes, which is a common result of the ball-milling process (45). It can be seen in
Figure 3.1B (with higher magnification) that small particles had agglomerated into larger
particles.
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Figure 3.1 SEM micrographs of the ball-milled PNIPAM microgel particles with (A) 996X,
10KV and (B) 3KX, 10KV magnifications.
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The hydrodynamic diameter of PNIPAM microgel particles in suspension and changes
with temperature were assessed with DLS analysis. The PNIPAM hydrogel produced via the
method developed by Haraguchi et al (41) absorbs water (hydrophilic) below the transition
temperature (~33°C) and shrinks and expels water (hydrophobic) above the transition
temperature (41). Microgels made from PNIPAM hydrogel were evaluated by DLS analysis of
the aqueous suspension of PNIPAM microgel particles over the temperature range of 20-50°C
with three measurements performed at each temperature interval. Moreover, the validity of
hydrodynamic diameter measurements was assessed by assuring that the count rates (photons
detected per second) were in the valid range (above 10KCPS, determined by the DLS instrument
manufacturers) and had no fluctuations (42,43).
Figure 3.2A shows the measured hydrodynamic diameters (blue line) and the count rates
(red line) for the PNIPAM microgel particles at the concentration of 3 Wt%, which is the same
concentration used for the core fluid of the electrospinning process. Two regions can be seen in
the curves of Figure 3.2A; 20-34°C and 34-50°C. In the region of 20-34°C, the count rates were
in the valid range and had no fluctuations, showing a valid hydrodynamic diameter
measurement. Hence, the average hydrodynamic diameter of PNIPAM microgel particles was
determined to be 511 ± 100 nm in the region of 20-34°C. When the temperature increased above
34°C, the hydrodynamic diameter increased and the measurements at each temperature interval
had higher variations. The increase of the hydrodynamic diameter accompanied by the increased
fluctuations of the count rate curve in this region (34-50°C) indicated that agglomeration of
PNIPAM microgel particles occurred and the measured hydrodynamic diameter was no longer
valid due to the particle-particle interactions. The observed behavior is consistent with the lower
critical solution temperature behavior of the PNIPAM microgel particles being hydrophilic and
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dispersed in between water molecules below the transition temperature, while becoming
hydrophobic and agglomerating above the transition temperature. Therefore, to inhibit the effect
of the particle-particle interactions in the measurements at 34-50°C, the concentration of
PNIPAM microgel particles in water was decreased gradually to find a concentration where the
count rate curve was stable and higher than 10KCPS. Figure 3.2B shows the measured
hydrodynamic diameters (blue line) and the count rates (red line) for the PNIPAM microgel
particles at the concentration of 0.005 Wt%, which was found to be suitable for DLS
measurements in the region of 34-50°C. It can be seen in Figure 3.2B that the count rate curve
was stable in the region of 34-50°C and the count rates were higher than 10KCPS. Hence, the
average hydrodynamic diameter of the PNIPAM microgel particles was determined to be 199 ±
10 nm above the transition temperature. Moreover, it can be seen in Figure 3.2B that the
hydrodynamic diameter curve had large fluctuations in the region of 34-50°C, which was due to
the low count rate i.e. invalid measurement (42,43).
The detailed DLS analysis of the PNIPAM microgel particle size distribution measured at
25°C and 40°C are shown in Table 3.1. At 25°C, particle size was variable. At 40°C, there was
one particle size showing the shrinkage of PNIPAM microgel particles above the transition
temperature. These results show that below the transition temperature, the PNIPAM microgel
particles take in water and expand to larger diameters and size distribution, while below the
transition temperature, the PNIPAM microgel particles expel water and collapse into smaller
diameters.
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Figure 3.2 The temperature-dependent hydrodynamic diameter (blue line) and the count rate (red
line) of PNIPAM microgel particles with the concentration of (A) 3 Wt% and (B) 0.005 Wt%.
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Table 3.1 The hydrodynamic diameter distribution of PNIPAM microgel particles measured at
25°C and 40°C.
Temperature: 25 (°C), Count rate: 371 (KCPS), PDI: 0.699
Size (nm)

Intensity (%)

SD (nm)

Peak 1

122

64.1

48.9

Peak 2

1425

21.4

579

Peak 3

4660

8

822

Temperature: 40 (°C), Count rate: 131 (KCPS), PDI: 0.182

Peak 1

Size (nm)

Intensity (%)

SD (nm)

215

100

62.8

The thermoresponsive behavior of PNIPAM hydrogel (before ball-milling) and PNIPAM
microgel particles (after drying, ball-milling, and resuspension in water) was characterized using
calorimetry. The thermoresponsive transition of PNIPAM hydrogel and the microgel particles
are represented by endothermic peaks on DSC thermograms in Figure 3.3. PNIPAM hydrogel
had an endothermic peak with onset temperature (Tonset) at 33.3°C which indicated the starting
point of the transition. The peak temperature (Tpeak) at 34.4°C can be considered as the transition
temperature. In addition, the enthalpy of transition (∆H) of 0.187 J/g shows the energy required
for this transition. Comparison of PNIPAM hydrogel to the suspension of the PNIPAM microgel
particles showed a slight increase of the Tonset to 33.7°C, Tpeak to 35°C, and ∆H to 0.203 J/g. The
observed slight increases can be explained by an increase of water content in the suspension (46).
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These results confirm that the PNIPAM microgel particles maintained thermoresponsive
behavior after drying and ball-milling.

Figure 3.3 DSC thermograms of (——) the PNIPAM hydrogel and (- - -) ball-milled PNIPAM
microgel particles in an aqueous suspension of 3 Wt%.
Characterization of the core-shell structured fibers
Morphology of the electrospun fibers was assessed using FESEM imaging of the gold
coated fibers. Figure 3.4A and 3.4B show FESEM micrographs of the sample F-AgHG with
10KX and 30KX magnifications, respectively. It can be seen in Figure 3.4A that F-AgHG fibers
were continuous and randomly aligned. Moreover, few beads were detected throughout the
FESEM assessment of the fiber meshes. Figure 3.4B shows the F-AgHG fibers at higher
magnification of 30KX. Some microcracks can be seen on the surface of thinner fibers and some
dimples can be seen on the surface of thicker fibers, which have been suggested to be the result
of the PCL and PEG phase separation during the electrospinning (47). Fiber diameter distribution
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of sample F-AgHG, measured with ImageJ analyzer software, is shown in Figure 3.5. The
average fiber diameter was 570 ± 394 nm and the highest frequency of fiber diameter was in the
range of 400-600 nm. The fiber structure was of sufficient quality to achieve the nanoparticles
delivery goals of the current study. Nevertheless, we propose that it is likely that the fiber
structure could be further improved using an electrospinning instrument with more controlled
processing conditions.
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Figure 3.4 FESEM micrographs of electrospun fibers containing PNIPAM microgel particles and
Ag NP in the core (sample F-AgHG) (A) before immersion in 10KX magnification, (B) before
immersion in 30KX magnification, (C) after one-week immersion at 20°C in 30KX
magnification, (D) after one-week immersion at 37°C in 30KX magnification, (E) after twoweek immersion at 20°C in 30KX magnification, and (F) after two-week immersion at 37°C in
30KX magnification.
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Figure 3.5 Fiber diameter distribution of fiber mesh F-AgHG before pore formation.
Formation of core-shell structured fibers was demonstrated using confocal imaging with
fluorescent dextran was added to the core solution to provide a contrast between the fiber core
and shell. The fluorescent and transmitted light images are shown in Figure 3.6, indicating the
core and the shell. A discrete margin can be seen between the core and the shell in these images
showing no mixing of the core and the shell solutions during the electrospinning process. In
addition, no leakage of the core was observed during the confocal imaging of the fibers. Imaging
of the control fibers (without the addition of fluorescent dextran) was performed to rule out
possible background of autofluorescence of fiber components. As expected, confocal images of
the control sample had no fluorescent signal confirming that none of the materials used for
fabrication of fibers had any background autofluorescence that could have created image artifacts
(data not shown).
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Figure 3.6 Confocal laser scanning micrographs of a fiber of sample F-AgHG: (A) fluorescence
channel image, (B) transmitted light channel image, and (C) overlay image.
Characterization of the pore formation in the fiber shell
Pore size and structure, formed via selective dissolution of PEG during immersion in
water, was characterized using FESEM imaging. In addition, the effect of immersion
temperature on the pore structure was determined. Figure 3.4 shows FESEM micrographs of the
F-AgHG fibers after one week (C and D) and two weeks (E and F) of immersion at 20°C or
37°C, respectively. It can be seen in these images that pores were formed, and the fiber structure
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was preserved after one or two weeks of immersion at both temperatures. There were no
apparent differences between the pore structure at 20°C or 37°C (Figure 3.4C and 3.4E,
compared to Figure 3.4D and 3.4F). The similar pore structure at both temperatures can be
explained by the high solubility of PEG, which results in its fast dissolution at both temperatures,
and thus pore formation within a few minutes of immersion (48). Moreover, there were no
changes in the pore structure between one and two weeks of immersion, showing no detectable
degradation of fibers.
The degradation of fiber meshes was evaluated by measuring the percent weight loss
after immersion. The percent total weight loss of the fiber mesh (F-AgHG) after one and two
weeks of immersion at 20°C and 37°C are shown in Table 3.2. The percent total weight loss of
one- and two-week immersed fiber meshes were slightly lower at 20°C compared to 37°C and
not significantly different. The weight loss (%) observed during the first week was mostly due to
the pore formation (dissolution of PEG) and the smaller weight loss observed afterward was
most likely due to the minor fiber degradation. Weight loss during the second week of immersion
was low at 20°C and 37°C, suggesting minor degradation of fibers at these temperatures. The
minor degradation was confirmed with FESEM imaging.

Table 3.2 Percent total weight loss (± SD) after one- and two-week immersion of F-AgHG fiber
meshes at 20°C and 37°C.

Weight loss % ( SD)

Immersed at 20°C

Immersed at 37°C

One-week immersion

26.5 ( 0.54)

27.2 ( 0.8)

Two-week immersion

27.3 ( 0.72)

28.2 ( 0.65)
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BET surface area and pore volume analysis was performed on the F-AgHG fiber meshes
before and after one-week immersion at 20°C or 37°C to quantify the changes of the fiber
surface area and pore volume (Table 3.3). It can be seen in Table 3.3 that both surface area and
pore volume increased after one-week immersion at both temperatures. These results confirm
pore formation in the fiber shell with immersion at these temperatures. Moreover, the nitrogen
adsorption and desorption isotherms had the same profile for all the samples (graphs not shown).
These results corroborate similar pore structures as were seen in the FESEM images (Figure 3.4)
of samples immersed at 20°C or 37°C and explained by the high solubility of PEG at both
temperatures. However, the increases in the surface area and pore volume were about two-fold
larger at 37°C compared to 20°C. This could be due to an increased degradation rate of fiber
surface at 37°C, which could result in deeper pores or rougher fiber surface (more shallow
features on the surface). Therefore, it should be noted that the presence of a higher number of
deep pores (connected to the core) can also affect the nanoparticle release rate at 37°C compared
to 20°C. Neither of these possibilities (presence of more deep pores or more shallow features)
was detected with FESEM imaging described above, thus further analysis with higher resolution,
such as atomic force microscopy, could help to further evaluate the surface structure and its
effect on nanoparticle release.
Table 3.3 BET surface area and pore volume results for the F-AgHG fiber mesh before
immersion and after one-week immersion at 20°C or 37°C.

Before immersion
Surface area (m2/g)

One week immersed

One week immersed

at 20°C

at 37°C

501

956

172

114

Pore volume (cm3/g)

0.35

0.98

1.82

Tensile properties
Mechanical properties of the fiber mesh F-AgHG before immersion, and after one- and
two-weeks immersion at 20°C or 37°C were assessed via a tensile test (Figure 3.7). The average
ultimate tensile strength, elongation at the break, and Young’s modulus measured for three
samples at each group are reported in Table 3.4. After one-week immersion, compared to nonimmersion, tensile strength and elongation at break had large increases at 20°C or 37°C
immersion temperatures, while Young’s modulus decreased at both temperatures. Compared to
one-week immersion, after two-week immersion, the tensile strength and elongation at break
decreased for both temperatures, with larger decreases at 37°C. Young’s modulus showed no
significant change at either temperature after two weeks.
The improvement of mechanical properties seen in this study can be explained with the
annealing of the fiber shell, which provides the mechanical foundation of the core-shell fibers
(44). The immersion temperatures of 20°C or 37°C are both in the annealing temperature range
of PCL (49), thus the improvement of mechanical properties observed at these temperatures after
one-week immersion was due to the annealing mechanism. However, a higher annealing
temperature (37°C) also facilitates the degradation mechanism which nullifies the annealing
effects (49). The greater degradation at 37°C was confirmed with the higher weight loss
observed for fibers immersed at 37°C (compared to 20°C). Consequently, a greater decrease in
tensile properties was seen for F-AgHG fiber mesh after the second week of immersion at 37°C.
It should be noted that the decline in mechanical properties during the second week of immersion
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was small (similar to the weight loss) and the tensile properties were still superior to the nonimmersed fiber mesh.
Taken together, these results demonstrate the mechanical stability of the fibers, which
was provided by the fiber shell (PCL matrix). However, in previous fiber designs, PNIPAM
provided the mechanical foundation of fibers causing poor mechanical properties (15–19).
Mechanical stability is crucial for achieving a controlled release of nanoparticles, especially for
long-term uses. For example, weak fiber structure causes undefined and unstable pore structure,
which results in an uncontrolled release.

Figure 3.7 Stress-strain curves of sample F-AgHG before immersion and after immersion for one
and two weeks at 20°C or 37°C.
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Table 3.4 Measured tensile properties (ultimate tensile strength, elongation at break, and
Young’s modulus) of non-immersed fiber mesh F-AgHG and, one- and two-week immersed at
20°C or 37°C. The SD for n=4 is reported in the parentheses for each measurement.

Ultimate Tensile

Elongation at

Young’s

Strength (KPa)

Break (%)

Modulus (KPa)

Non-immersed

1059 ( 81.7)

31.1 ( 3.71)

152 ( 8.61)

One-week immersed at 20°C

1793 ( 101)

94.3 ( 6.88)

103 ( 7.13)

One-week immersed at 37°C

1860 ( 168)

86.8 ( 4.12)

122 ( 14.3)

Two-week immersed at 20°C

1596 ( 138)

86.8 ( 4.12)

115 ( 14.3)

Two-week immersed at 37°C

1438 ( 70.1)

46 ( 2.47)

120 ( 4.64)

Release of nanoparticles
The release profile of Ag NP from the fiber mesh containing PNIPAM microgel particles
in the core (F-AgHG) was determined at two temperatures, 20°C and 37°C (Figure 3.8). ICP-MS
analysis was used to measure the released Ag both in the ionic form and Ag NP. The samples of
fiber meshes were immersed in water and at the predetermined time intervals, water samples
were collected and analyzed using ICP-MS for the presence of Ag. The nanoparticle release
study was performed over the course of two weeks to reflect the long-term use of the electrospun
fibers for various applications. Figure 3.8A shows the Ag release profile during the first 8 hours
of immersion of F-AgHG fiber meshes at 20°C and 37°C. The amount of released Ag from FAgHG fiber mesh after one hour of immersion were 5% and 12% at 20°C or 37°C, respectively,
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showing no burst release. These results show the advantage of using PNIPAM microgel
particles, compared to a non-crosslinked polymer, to avoid the burst release.
Figure 3.8B shows the Ag release profile during the two-week immersion of F-AgHG
fiber meshes at 20°C and 37°C. The cumulative Ag release was 34% after two weeks of
immersion at 20°C, increasing to 94% after two weeks of immersion at 37°C, or about three (2.8)
times faster release rate at 37°C compared to 20°C. This result confirms the thermoresponsive
and sustained release of nanoparticles from the fibers, which was achieved via the application of
PNIPAM microgel particles in the fiber core and having improved mechanical properties and
pore structure in the shell.
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Figure 3.8 Cumulative release of Ag for the fiber mesh F-AgHG at 20°C or 37°C (A) during the
first 8 hours of immersion and (B) during the two-week immersion period.
The amount of ZnO NP released from the shell was also measured using ICP-MS. The
release profiles of Zn during the two-week immersion of F-AgHG at 20°C or 37°C are shown in
Figure 3.9. No burst release was observed in any of the Zn release profiles, suggesting the
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association of the ZnO NP mostly with the PCL phase of the fiber shell rather than PEG, which
has a fast dissolution rate (44).
Sample F-AgHG immersed at 37°C had a faster sustained Zn release rate compared to the
sample F-AgHG immersed at 20°C, showing a temperature-dependent release of Zn. Desorption
or leaching of ZnO NP exposed to water on the surface of the fibers was suggested as the release
mechanism for Zn (44). Higher molecular interactions at the interphase of the fiber surface and
water at higher temperature (37°C) (50) results in the increased rate of Zn release. The increased
surface interactions and increased release of ZnO NP were also confirmed with the slightly
higher weight loss (Table 3.2) and surface area (Table 3.3) observed for the fiber mesh F-AgHG
at 37°C compared to 20°C.

Figure 3.9 Cumulative release of Zn during the two-week immersion period of fiber mesh FAgHG at 20°C and 37°C.
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Release of PNIPAM microgel particles
The possibility of PNIPAM microgel particles being released from fiber meshes was
investigated by measuring the OD450 of water samples after two-week immersion of fiber meshes
at 20°C and 37°C. The OD450 measurements did not show any detectable presence of PNIPAM
microgel particles (data not shown). The detection limit of the OD450 measurement was
calculated to be 5.3% of the PNIPAM microgel particles loaded in the fiber core of samples.
Therefore, it can be concluded that at least more than 94.7% of the loaded PNIPAM microgel
particles remained associated in the fibers, inside the core.
This result is important for future biomedical applications of the designed fibers. This
fiber design allows for the application of various microgels regardless of their biocompatibility
inside a fiber core because microgel particles remain inside the fiber core and do not release into
the tissue through an inconsistent pore structure or mechanical failure of the fibers.
Conclusions
Ball-milling of dried hydrogels was introduced in this study as a simple, versatile, and
high-yield method for production of microgel particles. Thermoresponsive PNIPAM hydrogel
was synthesized in the bulk form, dried, and ball-milled to produce microgel particles. The
PNIPAM microgel particles were then resuspended in water. DLS and DSC analyses showed
that the thermoresponsive property of the PNIPAM microgel particles was maintained, i.e. the
ball-milling method did not affect the stimuli-responsive properties of the microgel. The main
advantage of this method is avoiding the complex chemical processes, which usually requires the
use of toxic organic solvents and limits the potential to develop microgel particles with specific
properties. For other applications, microgel particles can be filtered to achieve narrow particle
size distribution.
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A temperature-controlled delivery of nanoparticles was obtained via application of the
PNIPAM microgel particles (loaded with Ag NP as a model antibacterial drug) inside the core of
electrospun fibers. Loading of the microgel in the core prevents unwanted reactions of the
microgel with the electrospinning solvents and possible phase transition during electrospinning.
The fiber meshes with PNIPAM microgel particles in the core had superior mechanical stability
with increased ductility and strength after immersion in water. At least 94.7% of the PNIPAM
microgel particles remained inside the fiber core during the two-week immersion period.
Preventing direct contact of the microgel particles and the tissue reduces possible toxicity.
Subsequently, biocompatible fiber meshes with various properties can be developed using
microgels with specific properties. In future applications, various fragile or bioactive therapeutic
agents can be delivered using this design and be protected from the harsh condition of
electrospinning or crosslinking.
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Supplementary data of chapter 3
Table 1. The Holm-Sidak's multiple comparisons test results for the total weight loss of
fiber meshes with immersion at 20°C and 37°C reported in Table 3.2. Asterisks indicate
significant difference ****p < 0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
Immersed at 20°C vs. Immersed at 37°C
One-week immersion

ns

Two-week immersion

ns
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Table 2. The Holm-Sidak's multiple comparisons test results for measured tensile
properties of non-, one-, and two-week immersed fiber mesh F-AgHG at 20°C and 37°C reported
in Table 3.4. Asterisks indicate significant difference ****p < 0.0001, ***p < 0.0002, **p <
0.0021, *p < 0.0332, nsP > 0.1234.

Non-immersed vs. One-week
immersed at 20°C
Non-immersed vs. One-week
immersed at 37°C
Non-immersed vs. Two-week
immersed at 20°C
Non-immersed vs. Two-week
immersed at 37°C
One-week immersed at 20°C vs.
One-week immersed at 37°C
One-week immersed at 20°C vs.
Two-week immersed at 20°C
One-week immersed at 20°C vs.
Two-week immersed at 37°C
One-week immersed at 37°C vs.
Two-week immersed at 20°C
One-week immersed at 37°C vs.
Two-week immersed at 37°C
Two-week immersed at 20°C vs.
Two-week immersed at 37°C

Ultimate Tensile

Elongation at

Young’s

Strength

break

Modulus

****

****

***

****

****

**

****

****

**

**

**

**

ns

ns

ns

ns

ns

ns

**

****

ns

*

ns

ns

***

****

ns

ns

****

ns
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Table 3. The Holm-Sidak's multiple comparisons test results for the percent cumulative release
of Ag from fiber meshes reported in Figure 3.8B. Asterisks indicate significant difference ****p
< 0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
F-AgHG at 37°C vs. F-

F-Ag20 at 37°C vs. F-

F-Ag20 at 37°C vs. F-

AgHG at 20°C

AgHG at 37°C

AgHG at 20°C

1h

ns

***

****

2h

***

*

****

8h

****

ns

****

24h

****

ns

****

72h

****

ns

****

168h

****

*

****

336h

****

***

****
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Table 4. The Holm-Sidak's multiple comparisons test results for the percent cumulative release
of Zn from fiber meshes reported in Figure 3.9. Asterisks indicate significant difference ****p <
0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
F-AgHG at 37°C vs.

F-Ag20 at 37°C vs. F-

F-Ag20 at 37°C vs.

F-AgHG at 20°C

AgHG at 37°C

F-AgHG at 20°C

1h

ns

ns

ns

2h

ns

ns

ns

8h

ns

ns

ns

24h

ns

*

**

72h

****

***

****

168h

****

****

****

336h

****

****

****
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Chapter 4: In vitro and in vivo evaluations of
electrospun fiber meshes
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Abstract
In vitro studies are of the primary steps in development of new biomaterials. In vitro studies
provide rapid information on efficacy of potential biomaterials. In vitro studies are fast, cost
efficient, and have fewer ethical restrictions, however, they cannot accurately mimic a live
biological system. In vivo studies are of the next steps to be performed for extrapolating
information on the expected performance and safety of biomaterials when in use. In vivo studies
are especially important in development of drug delivery systems because body biokinetics can
alter the drug release mechanisms in unpredicted ways. In this study, drug delivery performance
of developed fiber meshes was thoroughly evaluated in vitro and in vivo. Fiber meshes were
loaded with silver nanoparticles (Ag NP) and the delivery rate was controlled via application of
different sizes of NP and via application of thermoresponsive poly(n-isopropylacrylamide)
(PNIPAM) hydrogel particles. Fiber meshes also contained ZnO NP which have antibacterial
and wound healing properties. In vitro studies showed antibacterial efficacy of the fiber meshes.
In vivo studies showed continuous release of Ag NP during 27 days of subcutaneous
implantation. ZnO NP induced cytotoxicity in vitro while improved the wound healing and hair
regrowth in vivo.
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Introduction
Development of alternative drug delivery systems has gained attention in pharmaceutical
research to improve effectiveness of treatments, prevent or reduce side effects of drugs, decrease
costs and patient discomfort (1–4). With new delivery systems, unpredicted changes in the
performance of such systems can result in toxicity and/or reduce the efficacy of the intended
drug delivery. Therefore, it is vital to perform a thorough validation of such systems to ensure
that quality performance of any new system is maintained without introducing unusual effects.
There are a number of steps involved in the process. Dissolution/immersion testing also known
as “in vitro release testing” is an important initial quality control test for predicting the in vivo
performance of drug delivery systems after it was officially approved in 1970 (5,6). However,
considering the complexity of the dynamics and structure of human body, the in vitro release
testing method falls short of safely predicting in vivo performance.
The situation is more complicated when working with nanoparticles or smart drug
delivery systems since they are novel, more difficult to characterize, and often have unique
properties (7). Since no standard in vitro testing has been developed for quality and performance
testing of nanoparticles and smart drug delivery systems, in vivo animal study is still the most
reliable testing method (8,9). Therefore, in vitro antibacterial and cytotoxicity assays in addition
to animal studies need to be performed to ensure the quality performance of the fiber meshes
especially those using novel materials such as nanoparticles.
In prior work, fiber meshes were designed to achieve controlled and smart delivery of
nanoparticles (10,11). The fibers have a core-shell structure containing silver nanoparticles (Ag
NP, as a model drug) loaded inside fiber core and include pores formed in the fiber shell to
provide a release pathway. The pore structure and mechanical stability of the fibers were
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improved via novel use of zinc oxide nanoparticles (ZnO NP). Three different release rates were
achieved via application of 20 nm Ag NP, 110 nm Ag NP, and a mixture of both nanoparticles in
the core. Drug delivery with controlled rate was further upgraded to a smart delivery by applying
thermoresponsive Poly(n-isopropylacrylamide) (PNIPAM) microgel particles inside the fiber
core. In vitro release testing confirmed the temperature-controlled release of Ag NP.
In the current study, in vitro antibacterial efficacy of the fiber meshes was determined.
An MTS assay was used to evaluate the in vitro cytotoxicity of A549 epithelial cells by the fiber
meshes. Subcutaneous implantation of the fiber meshes in a mouse model was performed to
confirm the in vivo release of Ag NP form the fiber meshes. The subcutaneous implantation of
fiber meshes, which can represent in vivo drug delivery performance for cancer treatment (3,12),
tissue engineering (13–15), and wound healing (16,17) applications, was performed on a mouse
model. Biocompatibility, wound healing, anti-infection, and biodegradation properties of the
fiber meshes were assessed during the 27 days of implantation.
Materials and methods
Fiber meshes loaded with 20 nm Ag NP (F-Ag20 and F-AgHG) were chosen for the in
vitro and in vivo studies since they had the fastest release rate of Ag NP (10,11). Fiber meshes FPPZn and F-PP were used as negative control for Ag NP and ZnO NP, respectively. The data in
Table 4.1 represent the designation and composition of the fiber meshes used in this study.
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Table 4.1 The core and shell compositions of fabricated fiber meshes and their corresponding
sample name.
Shell composition
Sample

Core composition

PCL

PEG

(Wt%) (Wt%)
F-Ag20
F-AgHG

0.02 Wt% Ag NP
0.01 Wt% Ag NP +
3 Wt% PNIPAM Microgel particles

ZnO NP
(Wt%)

14

7

1.6

14

7

1.6

F-PPZn

Water

14

7

1.6

F-PP

Water

14

7

-

Antibacterial assay
E. coli (Migula Castellani and Chalmers, ATCC® 29842, USA) bacteria were cultured in
standard Luria-Bertani (LB, InvitrogenTM , Gibco®, USA) medium on a shaker (150 rpm, 0.3 cm
orbit motion, Thermo Labline 4625 Titer Shaker, USA) in an incubator (37°C). Initial incubation
of bacterial suspension was continued until an OD600 of 0.1 was obtained, then it was used as the
bacterial stock. Measurements at OD600 were used as a monitor of bacterial growth in a similar
manner as previously described (18). The OD600 was measured by transferring 100 µL of
bacterial aliquots into 96 microwell plates and reading the optical density at 600 nm (OD600,
SpectraMax M4 multi-mode microplate reader, Molecular devices, USA) to determine bacterial
activity.
In order to determine the antibacterial potential of each of the fiber mesh, four equal
pieces were cut out of each fiber meshes (F-AgHG, F-Ag20, F-PP and F-Zn) using a punch (12.7
mm diameter, Jenley hollow leather punch) then quickly detached from the aluminum foil in

139

water and placed in each well of 24-well plates. To investigate a possible effect of the PNIPAM
microgel particles on the antibacterial activity, a 200 µL suspension of 3 Wt% PNIPAM
microgel particles was added into separate wells. It was calculated that a total of 85 µL PNIPAM
microgel particles suspension was inside the fiber mesh samples used for the assay. Therefore, to
evaluate a possible antibacterial activity caused by PNIPAM microgel particles, 200 µL (which
is more than 85 µL for safe measurements) was used. Three replicate wells were used for each
measurement (error bars represent standard deviation (SD) for n=3).
Experiments were started (at 0 h) by addition of 2 mL of bacterial suspension from the
stock (with OD600 of 0.1) into each well. The control was 2 mL of bacterial suspension from the
stock added into empty wells. Cultures were continued for 24 hours and the OD600 measurements
were performed hourly for 10 h and then at 24 h to obtain the bacterial growth curves. PNIPAM
microgel particles become opaque at 37°C and could skew the OD600 measurements results.
Therefore, aliquots for OD600 measurements were gently collected by careful insertion of the
pipet tip into the bacterial suspensions to avoid collecting the PNIPAM microgel particles.
Cytotoxicity assay
The MTS assay was performed using A549 human lung epithelial cells obtained from
ATCC. Cells were suspended in Ham's F-12K (Kaighn's) Medium (GibcoTM by Life
TechnologiesTM, USA) supplemented with 10% fetal bovine serum, 250 ng/mL amphotericin B,
and 100 U/mL penicillin and Streptomycin in 75 cm2 flasks at 37 °C (all supplements provided
from Media Tech, Manassas, VA, USA). Since A549 cells are adherent, trypsin was used to
dislodge the cells for MTS assay. The cells were centrifuged at 950 x g for 4 minutes and the
cells were resuspended in 5 mL of media. A 40 µL volume was counted with a Z2 Coulter
Counter (Beckman Coulter, FL, USA).

140

Equal circles were cut from fiber meshes using a 5.5 mm diameter punch (Jenley hollow
leather punch, Yiwu Jiede Electronic Commerce Co.). Fiber meshes were immersed in water for
one hour to form pores required for Ag NP release. Fiber meshes were sterilized by soaking in
(100%) ethanol for 10 seconds then placed in 96-well plates to dry. Afterwards, 100 µL of the
A549 cell suspension was added into the wells at 15,000 cells/well and cultured for 24 hours.
Cell viability was determined using CellTiter assay (Promega, WI, USA) according to the
manufacturer’s protocol (19). Cell viability was calculated as the percent viable cells relative to
the control cultures (which had no fiber meshes). Blanks were also defined as media, without
cells, added to the fiber meshes. Data are the presented as mean ± standard error (SE) calculated
from three experiments with three replicates in each.
In vivo experimental design and surgical implantation
All animal procedures were approved by the Institutional Animal Care and Use
Committee of the University of Montana. Male and female C57BL/6 mice (7-8 weeks, 15-25 g
body weight) were used. Animals were grouped as skin control (no surgery), sham surgery
(surgery was performed without implanting a fiber mesh), and groups implanted with F-Ag, FAgHG, F-PPZn, F-PP fiber meshes. 24 h, 7 days, and 27 days were selected to observe the
outcomes from fiber mesh implants. Two male and two female mice were implanted for each
group and each time point. Fiber meshes were cut in squares (~ 6 mm × 6 mm) and soaked in
water then ethanol each for 10 seconds prior to surgery. For surgery, animals were anaesthetized
by intraperitoneally injecting 100 mg/kg body weight of a ketamine (80 mg/kg)/xylazine (12
mg/kg) cocktail with 9/1 volume ratio. The dorsal hair was shaved and skin was prepared with
ethanol (70%), povidone-iodine, and lidocaine (4%), alternatively. A 1.5 cm longitudinal cut was
created on the right dorsal flank and a pouch was created using forceps. Fiber meshes were
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implanted into the left side of the dorsal pouch and the incision was closed using surgical glue.
Animals were placed on heating pads to recover from anesthesia. Mice were housed individually
after the surgery and fed ad libitum.
Tissue collection and histological staining
After 24 h, 7 days, and 27 days, animals were euthanized by barbiturate overdose
injection. A square area of skin around the fiber mesh was cut with surgical scissors. Skin and
fiber mesh were dissected free of adherent tissue, placed in OCT compound (Sakura Finetek
USA Inc., CA, USA), and snap frozen using liquid nitrogen. To obtain cross-sections of tissue
samples, the frozen OCT blocks were cut at the center, placed vertically in OCT, and snap frozen
using liquid nitrogen. Tissue samples were cryo-sectioned into 10 µm sections. Sections were
stained with hematoxylin and eosin (H&E).
Hyperspectral microscopy
CytoViva hyperspectral microscopy (CytoViva Inc, Auburn, Al, USA) was used to
determine the release of Ag NP from fiber meshes into the mouse skin tissue. Hyperspectral
images were captured with CytoViva Micro-Manger 1.4 and processed with CytoViva ENVI 4.8
image analysis software. A spectral library was created from a hyperspectral image captured
from a dried droplet of Ag NP suspension on a slide. The created spectral library was filtered
against skin control and F-PP to exclude any non-specific match with tissue or the fiber mesh
without Ag NP. Subsequently, spectral Angle Mapper Classification was used to map the
matching pixels of Ag NP on the tissue samples.
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Statistical analyses
Statistical analyses were performed using a one- or two-way ANOVA followed by
individual comparison of groups using Holm-Sidak’s multiple comparisons test (PRISM v.7.0,
GraphPad, San Diego, CA, USA). The Holm-Sidak’s multiple comparison results are reported at
supplementary data of chapter 4. A statistical significance level of 5% (p < 0.05) was defined.
The minimum number of replicates was three. Values were reported as Mean ± SD.

Results and discussion
Antibacterial efficacy
Antibacterial efficacy of fiber meshes was evaluated from their ability to inhibit bacterial
growth, as shown in bacterial growth curves Figure 4.1. It can be seen in Figure 4.1 that the
starting OD600 was 0.1 for all samples, showing similar starting conditions. As expected, the
bacterial growth curve of the control increased continuously until the end of the experiment (24
h) excluding possible factors to limit bacterial growth, such as lack of nutrients. The bacterial
growth curves of sample HG-200µL had no significant difference from control, showing that the
PNIPAM microgel particles had no antibacterial activity. Similarly, the bacterial growth curve of
F-PP was not significantly different from the control. This result eliminates any possible masking
or interfering factors such as attachment of bacteria to the fibers or growth inhibitory effects of
PCL and PEG.
In contrast, significant (Supplementary Data Table 1) inhibition was seen from the
bacterial growth curves of fiber meshes F-Ag20, F-AgHG, and F-PPZn compared to the growth
curve of control, demonstrating highly effective antibacterial activity of the fiber meshes (18). In
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fact, after 24-hour incubation with the fiber meshes, bacterial growth curves decreased to an
OD600 of 0.46 which is the OD600 of broth without bacteria. The observed antibacterial activity
can be attributed to the release of Ag NP and ZnO NP (20). However, comparing the samples FAg20 and F-PPZn reveals that the antibacterial activity was dominated by ZnO NP. This result
could be due to the higher amount of ZnO NP in the shell (1.6 Wt%), compared to Ag NP in the
core (0.02 Wt%), and/or higher antibacterial activity of ZnO NP compared to Ag NP. It should
be noted that the primary purpose for including ZnO NP in this research was to achieve open
pores, but it was also an effective antibacterial (11).

Figure 4.1 Growth curves of E. coli during 24 h of incubation at 37°C with fiber meshes FAgHG ( ), F-PPZn (●), and F-Ag20 (◆) compared to the control (-), F-PP (▲), and HG-200 µL
(X). Asterisk indicates a significant difference of (*p < 0.0001, Supplementary Data Table 1).
Data are expressed as mean ± SD of n = 4.
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Cytotoxicity
In vitro MTS assays were performed to determine potential cytotoxicity of the fiber
meshes with cells in culture. The percent cell viability data relative to the control are presented in
Figure 4.2. The fiber mesh F-PP had the least effect on viability most likely due to absence of
ZnO NP and Ag NP. The reason for decrease in viability of F-PP compared to control was not
clear. Addition of ZnO NP into the fiber mesh F-PPZn reduced the cell viability to 28%
consistent with known ZnO NP cytotoxicity (21,22). The cell viability was slightly improved
(but not significant, Supplementary Data Table 2) when Ag NP were in the fiber meshes (FAg20 and F-AgHG). Similar results were reported with loading ZnO NP and Ag NP in
electrospun fiber meshes, concluding that application of both nanoparticles can reduce
cytotoxicity without affecting the antibacterial efficacy of fiber meshes (23). It should be noted
that the A549 cells are considered sensitive (24–26). Therefore, while the high sensitivity of
these cells helped to determine the source of the cytotoxicity (ZnO NP), it might not be the actual
representative of in vivo outcomes.
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Figure 4.2 A549 lung epithelial cell viability in an in vitro 24 hours culture measured by MTS
assay. Data are expressed as mean ± SE of n = 4.
Surgical implantation of fiber meshes
General appearance of the skin with surgical implants
The fiber meshes were appeared to have been well-tolerated by all animals. No sign of
irritation or infection was observed at any of the time intervals. Fiber meshes had good
adherence and did not move from the implantation site i.e. the left dorsal flank. However, fiber
meshes were folded in some animals. When collecting tissue samples, fiber meshes were easily
released from the adjacent tissues (skin or muscle) at 24-hour and 7-day time intervals. After 27
days of implantation, fiber meshes of all groups (excluding the F-PP group) were attached to the
underlying muscle. Moreover, some capillary formation could be seen on the fiber meshes after
27 days of implantation. Images of the animals at 27 days after surgery are presented in Figure
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4.3. Hair regrowth was faster for females compared to males in all groups. For all groups, hair
regrowth initiated from the site of surgical incision i.e. the right dorsal flank. Fiber mesh F-PP,
which had no ZnO NP or Ag NP, slightly decreased the hair regrowth in both male and female
mice. Fiber mesh F-PPZn, which had ZnO NP, improved the hair regrowth in both males and
females. However, addition of Ag NP into the composition of fiber mesh F-Ag20 decreased hair
regrowth. These results are in contrast to a previous study (27), in which, addition of Ag NP into
the electrospun fibers stimulated the hair regrowth of a rabbit model.

Fiber meshes with

PNIPAM microgel particles, F-AgHG, had a slightly better hair regrowth than F-Ag fiber
meshes. This result is most likely be due to the less total percent of Ag NP in fiber meshes FAgHG (0.01%) compared to F-Ag (0.02%).

Figure 4.3 Skin appearance of the mouse groups on 27 days post-surgery.
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Response of skin tissue to fiber implants
Skin samples collected after 24 hours, 7 days, and 27 days of implantation were stained
and examined for responses to the different fiber implants. Representative examples are
presented in Figure 4.4 for female mice and in Figure 4.5 for male mice. The normal skin (no
surgery) examples show the different structure of female and male mice. Female skin has more
adipose cells and more hair follicles (28,29). After 24 hours of implantation, edema was seen in
all groups with an increasing order of F-PPZn, sham, F-PP, F-AgHG, and F-Ag20. These results
show that addition of Ag NP induced edema while ZnO NP reduced the edema. Similar results
were observed in female and male groups, but with greater intensity in female mice. After 24
hours of implantation, some accumulation of neutrophils on the fiber mesh F-PP was seen in
male and female mice suggesting the presence of an infection or acute inflammation (30). After 7
days of implantation, neutrophil accumulation diminished. No edema was seen after 7 days in the
male and female sham surgery groups and the skin structure was similar to normal skin.
However, more hair follicles in female mice and less hair follicles in male mice were observed
compared to normal skin. After 7 days of implantation, edema was reduced, but not completely
eliminated, in all fiber mesh groups. After 7 days of implantation, some cell infiltration to the
fiber meshes was detected starting from the edges of fiber mesh. The lowest cell infiltration was
observed with F-PP. After 27 days of implantation, cell infiltration was greatest for F-Ag20 and
F-AgHG and less F-PPZn. Cell infiltration did not increase for F-PP after 27 days of
implantation. This result shows that Ag NP was responsible for inducing cell infiltration into the
fiber meshes. Slight degree of fibrosis formed around the fiber meshes after 27 days which
showed biocompatibility of the fiber meshes (31).
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Figure 4.4 Bright field micrographs of H&E stained skin samples of female mice collected at 24hour, 7-day, 27-days intervals compared to the normal skin. Blue, red, and green arrows denote
edema, neutrophils, and fibrotic tissue, respectively. All images are at 40X and scale bars are 200
µm.

Figure 4.5 Bright field micrographs of H&E stained tissue samples of male mice collected at 24hour, 7-day, 27-days intervals compared to the normal skin. Blue, red, and green arrows denote
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edema, neutrophils, and fibrotic tissue, respectively. All images are at 40X and scale bars are 200
µm.
Hyperspectral mapping of Ag NP
Our earlier studies with the fiber meshes demonstrated that Ag NP were released from the
fiber meshes into water (10,11). The antibacterial and cytotoxicity studies suggested that Ag NP
were released into biologically relevant media and had toxicity toward bacteria and cells. The
histology results suggested that Ag NP were released from the fiber meshes in vivo. CytoViva
hyperspectral imaging of the tissue samples was performed to demonstrate that Ag NP were
released from the fiber meshes. Figures 4.6, 4.7, and 4.8 present CytoViva hyperspectral imaging
of the female mouse skin collected after 24 hours, 7 days, and 27 days of implantation,
respectively. It can be seen in Figure 4.6 that after 24 hours of implantation, Ag NP were
released from the mesh, traveled through the dermis, and accumulated at hair follicles. This
result confirms release of Ag NP soon after implantation and ability of Ag NP to traverse from
the meshes through several cell layers to the hair follicles. Figure 4.7 shows that the
accumulation of Ag NP in hair follicles continued after 7 days of implantation. Figure 4.8 shows
a high accumulation of Ag NP along the hair shafts after 27 days of implantation. This result
confirms that Ag NP had a continuous release from fiber meshes over the period of 27 days
which resulted in a uniform accumulation inside the hair shafts as hair grew.
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Figure 4.6 CytoViva hyperspectral imaging of the female mouse skin collected after 24 hours
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and the overlaid images (C and F). Images taken at 50X magnification (A, B, and C) and
400X magnification (D, E, and F). Yellow arrows denote accumulated Ag NP in hair follicles.
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Figure 4.7 CytoViva hyperspectral imaging of female mouse skin collected after 7 days
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangular shows the region of the image taken at 400X magnification. Yellow arrows denote
accumulated Ag NP in hair follicles.
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Figure 4.8 CytoViva hyperspectral imaging of female mouse skin collected after 27 days
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and overlaid micrographs (C and F). Images taken at 100X magnification (A, B, and C)
and 400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin.
Yellow arrows denote accumulated Ag NP in hair shafts.
Figures 4.9, 4.10, and 4.11 present CytoViva hyperspectral images of male mouse skin
collected after 24 hours, 7 days, and 27 days of implantation, respectively. Figure 4.9 shows
accumulation of Ag NP in a hair follicle after 24 hours of implantation, which confirmed the
early release of Ag NP from the fiber mesh. However, skin samples of male mice had less hair
follicles compared to female mice and thus it was difficult to detect many hair follicles with Ag
NP accumulation. Figures 4.10 and 4.11 show that male skin samples had no hair follicles after 7
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and 27 days of implantation, and Ag NP were dispersed within the dermis. This result confirms
that Ag NP had a continuous release from the fiber mesh during the 27 days of implantation in
male mice, however, the released Ag NP had different distribution/accumulation behavior
compared to female mice. Similar results were observed for in vivo release of Ag NP from the
fiber meshes containing PNIPAM microgel particles (Figures 4.12, 4.13, 4.14, 4.15, 4.16, and
4.17).

Figure 4.9 CytoViva hyperspectral imaging of male mouse skin collected after 24 hours
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
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400X magnification (D, E, and F). The rectangle shows the region of the image taken at 400X
magnification. Yellow arrows denote accumulated Ag NP in the dermis.

Figure 4.10 CytoViva hyperspectral imaging of male mouse skin collected after 7 days
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangle shows the region of the image taken at 400X magnification. Yellow arrows denote
dispersed Ag NP in the dermis.
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Figure 4.11 CytoViva hyperspectral imaging of male mouse skin collected after 27 days
implantation of fiber mesh F-Ag20. Dark field images (A and D), spectral mapping of Ag NP (B
and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangle shows the region of the image taken at 400X magnification. Yellow arrows denote
dispersed Ag NP in the dermis.
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Figure 4.12 CytoViva hyperspectral imaging of the female mouse skin collected after 24 hours
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and the overlaid images (C and F). Images taken at 50X magnification (A, B, and C)
and 400X magnification (D, E, and F). Yellow arrows denote accumulated Ag NP in hair
follicles.
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Figure 4.13 CytoViva hyperspectral imaging of the female mouse skin collected after 7 days
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and the overlaid images (C and F). Images taken at 50X magnification (A, B, and C)
and 400X magnification (D, E, and F). Yellow arrows denote accumulated Ag NP in hair
follicles.
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Figure 4.14 CytoViva hyperspectral imaging of the female mouse skin collected after 27 days
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and the overlaid images (C and F). Images taken at 50X magnification (A, B, and C)
and 400X magnification (D, E, and F). Yellow arrows denote accumulated Ag NP in hair
follicles.
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Figure 4.15 CytoViva hyperspectral imaging of male mouse skin collected after 24 hours
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangle shows the region of the image taken at 400X magnification. Yellow arrows denote
dispersed Ag NP in the dermis.
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Figure 4.16 CytoViva hyperspectral imaging of male mouse skin collected after 7 days
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangle shows the region of the image taken at 400X magnification. Yellow arrows denote
dispersed Ag NP in the dermis.
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Figure 4.17 CytoViva hyperspectral imaging of male mouse skin collected after 27 days
implantation of fiber mesh F-AgHG. Dark field images (A and D), spectral mapping of Ag NP
(B and E), and overlaid images (C and F). Images taken at 100X magnification (A, B, and C) and
400X magnification (D, E, and F). The dashed lines show the tissue and fiber mesh margin. The
rectangle shows the region of the image taken at 400X magnification. Yellow arrows denote
dispersed Ag NP in the dermis.

Conclusions
In vitro and in vivo evaluations of the fiber meshes were performed in this study. In vitro
antibacterial activity of fiber meshes was shown and thus confirmed the potential for
antibacterial applications such as wound dressings. MTS assay results showed cytotoxicity of the
ZnO NP suggesting that the fiber meshes might not be appropriate for in vitro tissue scaffolding
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uses. In future studies, other nanoparticles can be explored for replacing ZnO NP to reduce
cytotoxicity.
Subcutaneous implantation of fiber meshes allowed monitoring of drug delivery into skin
tissue. The Ag NP started to release soon after implantation and continued to release over the
course of 27 days. In male mice, Ag NP were dispersed in the dermis layer while in female mice,
Ag NP accumulated in hair follicles. Different accumulation patterns of Ag NP in male and
female mice suggest the need to consider gender-specific drug delivery systems. Quantitative
measurements of drug release rates are needed to further understand the gender difference of
drug release. Ag NP reduced hair regrowth which was in contrast to previous reports (27,32,33).
More studies are needed to understand the mechanism(s) of Ag NP effects on hair growth. ZnO
NP enhanced wound healing and stimulated hair regrowth. These results suggested the use of the
fiber meshes for cosmetic applications. In vivo studies confirmed drug release, biocompatibility,
and mechanical stability of the fiber meshes and effective performance for prolonged drug
delivery applications.
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Supplementary data of chapter 4
Table 1. The Holm-Sidak's multiple comparisons test results for the OD600 measurements of the
antibacterial assay reported in Figure 4.1. Asterisks indicate significant difference ****p <
0.0001, ***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.

Control vs.

Control vs. F-PPZn,

F-PP,

Control vs. F-Ag20,

F-AgHG vs.

Control vs.

HG-200µL vs. F-

F-PP vs.

F-PPZn,

Control vs.

F-AgHG,

AgHG,

F-AgHG,

HG-200µL

F-AgHG vs.

HG-200µL

F-PP vs. F-

HG-200µL vs. F-

F-PP vs.

vs. F-PP

Ag20

PPZn,

F-PPZn

F-Ag20,
F-PPZn vs.

HG-200µL vs. F-

F-Ag20

Ag20

1h

ns

ns

ns

ns

ns

ns

2h

ns

ns

***

****

**

ns

3h

ns

ns

****

****

****

ns

4h

ns

ns

****

****

****

ns

5h

ns

ns

****

****

****

ns

6h

ns

ns

****

****

****

ns

7h

ns

ns

****

****

****

ns

8h

ns

ns

****

****

****

ns

9h

ns

ns

****

****

****

ns

10h

ns

ns

****

****

****

*

24h

ns

**

****

****

****

***

168

Table 2. The Holm-Sidak's multiple comparisons test results for A549 lung epithelial cell
viability results reported in Figure 4.2. Asterisks indicate significant difference ****p < 0.0001,
***p < 0.0002, **p < 0.0021, *p < 0.0332, nsP > 0.1234.
F-PP vs. F-PPZn

**

F-PP vs. F-Ag20

*

F-PP vs. F-AgHG

ns

F-PPZn vs. F-Ag20

ns

F-PPZn vs. F-AgHG

ns

F-Ag20 vs. F-AgHG

ns
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Summary
The goal of this study was to develop electrospun fibers with 1) prolonged and controlled
drug release, 2) suitable mechanical properties, 3) minimal toxicity, 4) and capable of loading
fragile drugs or bioactive agents. The primary aim while developing the fiber design was to
establish versatility that could be used in various applications. Figure 5.1 shows the designing
steps of the developed fibers.

Figure 5.1 Development steps of the core-shell structured fibers.
Core-shell structure fibers were developed with silver nanoparticles (Ag NP, as a model
drug) loaded inside the core. Formation of the core-shell structure was confirmed using
transmission electron microscopy and confocal laser microscopy (fluorescent imaging). Fiber
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diameter had a distribution with the highest frequency (mode) at 600-800 nm. The release
pathway for Ag NP was defined through the pores formed in the shell via selective dissolution of
the polyethylene glycol (PEG) as porogen. PEG has been used as a porogen for making pores in
previous studies (1–4). However, in those studies, high percentages of PEG in the shell
composition were needed to form open pores and thus the dissolution of PEG resulted in fiber
rupture/swelling and failure of the shell structure. The sudden collapse of fibers in turn resulted
in an uncontrolled and sudden release of the drug within one to a few hours (5,6). Therefore,
open discrete pore structure and mechanical stability were recognized as the two essential factors
to eliminate burst release and provide a prolonged release rate. Therefore, in my studies, I
obtained a modified pore structure using a a small percentage of ZnO NP (1.6%) added to the
shell simultaneously with the use of PEG (7%) as the porogen. Scanning electron microscopy
(SEM) showed that addition of ZnO NP increased the depth and size of pores while tensile
testing showed that mechanical properties improved. SEM imaging showed the formation of
mostly oblong pores in the surface of the fibers. The average pore width (perpendicular to the
fiber length) and length (parallel to the fiber length) were 70 ± 57 nm and 127 ± 64 nm,
respectively.
Subsequently, fine-tuned delivery rates were achieved via loading 20 nm Ag NP, 110 nm
Ag NP, or a mixture of the two sizes inside the fiber core. In vitro drug release studies showed
fast (79%), slow (36%), and intermediate (62%) delivery rates of these Ag NP during two-weeks
of immersion. Faster diffusion of smaller nanoparticles through the pores resulted in a faster
release/delivery rate along with slower diffusion of larger nanoparticles resulting in a slower
release/delivery rate.
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The function of fibers was further enhanced to smart delivery of therapeutic agents by
loading poly(n-isopropylacrylamide) (PNIPAM) microgel particles (in addition to Ag NP) inside
the fiber core. Formation of the core-shell structure was confirmed using fluorescent imaging.
SEM imaging showed that the highest fiber diameter frequency (mode) was at 400-600 nm. In
vitro drug release studies showed a temperature-responsive drug delivery of fiber meshes.
During two-weeks of immersion, Ag NP released 2.8-fold faster above the transition temperature
of PNIPAM microgel (94%) compared to below the transition temperature (34%).
Ball-milling was developed as a simple, non-toxic, and high-yield method to produce
PNIPAM microgel particles. Differential scanning calorimetry (DSC) analyses confirmed that
the PNIPAM microgel particles maintained thermoresponsive behavior after the drying and ball
milling processes. Dynamic light scattering (DLS) measurements showed that the average
hydrodynamic diameter of PNIPAM microgel particles was 511 ± 100 nm below the transition
temperature and 199 ± 10 nm above the transition temperature. Spectrophotometric analyses of
the in vitro drug release water samples confirmed that more than 94.7% of the loaded PNIPAM
microgel particles remained associated inside the fiber core.
In vitro and in vivo performances of the fiber meshes were evaluated in the final steps of
this study. In vitro tests showed the antibacterial efficacy of the fiber meshes. Fiber meshes had a
prompt growth inhibition effect when exposed to bacteria and effectively eliminated bacterial
after 24 hours of incubation. In vitro MTS assays using human epithelial cells showed that
cytotoxicity of the fiber meshes occurred and was caused by ZnO NP. The application of Ag NP
reduced cytotoxicity, but not significantly.
Subcutaneous implantation of the fiber meshes in a mouse model was performed to
investigate the in vivo drug delivery performance of the fiber meshes for applications such as
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tissue engineering, wound dressings, and cancer treatment. Ag NP were released soon after
implantation and continued to release over the course of 27 days. However, evaluation of skin
showed different accumulation patterns of the released Ag NP in female and male mice. In
female mice, the Ag NP accumulated in the hair follicles and were expelled into the hair shaft as
it grew. However, Ag NP dispersed within the dermis in male mice. Ag NP induced edema
during 24 hours of implantation and reduced hair regrowth during 27 days of implantation. ZnO
NP induced less edema during 24 hours of implantation and enhanced the hair regrowth and
wound healing during 27 days of implantation. Fiber meshes had appropriate biocompatibility
and no infection was detected. The mechanical stability of fiber meshes was maintained after 27
days of implantation. In vivo drug release studies confirmed the potential of the fiber meshes for
prolonged drug delivery applications.
Conclusions and future directions
The main advantage of the fiber meshes was versatility for applying different kinds of
drugs or nanoparticles to be used for various applications. Bioactive or fragile therapeutic agents
can be loaded inside the fiber core while being protected from organic solvents and harsh
conditions of electrospinning. Drugs can be produced in the form of nanoparticles or can be
loaded on nanoparticles. Simultaneous delivery of several drugs with individually controlled
delivery rates can be achieved by loading different sizes of drug nanoparticles.
Future work needs to be performed for to explain the mechanism(s) to account for how
ZnO NP improved the pore structure and mechanical properties, and the fluid dynamic inside the
fiber core.
PNIPAM microgel can be replaced by other stimuli-responsive microgels to achieve
different smart delivery systems. The advantage of using the stimuli-responsive polymers in the
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form of microgel (i.e. cross-linked) is avoiding the sudden release into the tissue site and thus
preventing/reducing possible toxicity. Loading microgel particles inside the core prevents
undesired phase transition of stimuli-responsive microgels caused by electrospinning conditions
and solvents.
The ball-milling method that was developed in this research allows for producing various
microgel particles with specific properties while avoiding the chemical complexities of
synthesizing microgels. Microgel particles can be filtered to achieve a narrow particle size
distribution. Future work needs to be performed to determine a possible connection between the
hydrogel synthesis method and the final shape and size distribution of the microgel particles.
The fiber meshes can be used for prolonged anti-infection applications such as wound
dressings and tissue replacements. However, they are not suitable for in vitro tissue engineering
applications due to the cytotoxicity of ZnO NP. In future work, other nanoparticles should be
explored to replace the ZnO NP for reducing the cytotoxicity. Unlike the in vitro results, the in
vivo implantation showed the benefits of ZnO NP to enhance wound healing and hair regrowth.
Therefore, the application of ZnO NP had various advantages including forming open pores,
improving mechanical properties, antibacterial properties, and wound healing enhancement.
Moreover, the enhanced hair regrowth suggests potential cosmetic applications of ZnO NP. The
different accumulation patterns of Ag NP in male and female mice suggests the need for genderspecific drug delivery designs. In future work, quantitative measurements of in vivo release rates
and examination of other organs that Ag NP might traverse to (such as lymph nodes), in male
and female mice, should be performed to improve the design and performance of the drug
delivery systems.
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